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MEASUREMENTS OF MINERALIZATION DENSITY PROFILES IN BONE 
FORMATION SITES: A NOVEL TOOL FOR DIAGNOSIS OF DISTURBANCES 
IN PRIMARY MINERALIZATION OF BONE. 
 
ABSTRACT 
The degree of bone matrix mineralization is playing a pivotal role in tuning stiffness, 
strength and toughness of bone and is therefore an important determinant of bone quality. 
Mature trabecular and osteonal bone is composed by bone structural units (BSU) 
mineralized up to different degrees of mineral content, which generates a characteristic 
bone mineralization density distribution (BMDD). Young BSUs have the lowest and old 
BSUs the highest degree of mineralization. The exact knowledge of the underlying 
mineralization process is still lacking, but it could be shown that once mineralization has 
been started in the newly formed bone matrix (osteoid) the mineral content is rapidly 
increasing within few days up to 70 % of its final value and is referred as primary 
mineralization. The last 30% of increase in mineral content occurs only slowly in a time 
scale of month to years and is referred as secondary mineralization. The present work 
focuses on the measurement of the Ca-content where the transition from fast to slow 
mineralization occurred, which had been designated by us as CaTURN. Such measurements 
would allow us to detect bone diseases affecting the primary mineralization process and to 
contribute in the development of therapeutic strategies directly targeting the mineralization 
process. 
 For this purpose sectioned bone areas of human transiliac biopsies embedded in 
polymethylmethacrylate were imaged with a pixel resolution of 0.5 !m by quantitative 
backscattered electron imaging (qBEI). BSUs exhibiting a mineralization front were 
selected for analyses of mineralization density profiles (BM-profiles) perpendicular across 
the mineralization front. The obtained data plots could be described by two linear fits of 
different slopes, an initial steep slope followed by a flat one. The intersection point of the 
two lines determined the value of CaTURN. 
Biopsies from children with a genetic disorders like osteogenesis imperfecta (OI-
type I, n=5 and OI-type VII, n=4) showed an increased CaTURN, while children with an 
autosomal dominant hypocalcemia (ADH) an inherited form of hypoparathyroidism caused 
by an activating mutation of calcium sensing receptor (CaR) (n=3) exhibited a decreased 
CaTURN , compared to healthy children (n=13). Biopsies from patients with postmenopausal 
osteoporosis (n=9) treated with Ca and Vit D had a CaTURN not different from that of adult 
controls (n=8), while patients with an unclear differential diagnosis of bone diseases 
(n=10) exhibited all a reduced CaTURN. When the CaTURN parameter where correlated with 
parameters of bone mineralization density distribution (BMDD) describing the average 
(CaMEAN) or the typical (CaPEAK) Ca-content of the entire cancellous bone compartment a 
strong positive linear correlation was revealed for the children with genetic disorders, 
while no such correlations were found for the adult patients. 
The data suggest that the investigated genetic disorders are affecting the primary 
mineralization process, and that the final amount of Ca-content the bone matrix is 
reaching, is some how predetermined by the primary mineralization process. This new 
findings also proves the concept that a pathological altered mean degree of mineralization 
of bone can be a result of altered bone turnover and / or intrinsic bone mineralization 
process. Indeed, the changes seen in BMDD of OI and CaR mutated patients seem to be 
predominantly an effect of changes in the primary mineralization process, while the effects 
seen in the adult patient group with metabolic bone diseases seems to be mainly due to 
changes in bone turnover.  
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DIE ANALYSE VON MINERALISATIONSPROFILEN AN 
KNOCHENNEUBILDUNGSZONEN: EIN NEUES DIAGNOSEVERFAHREN FÜR 
STÖRUNGEN DER PRIMÄREN KNOCHENMINERALISATION. 
 
ZUSAMMENFASSUNG 
Der Mineralisationsgrad der Knochenmatrix stellt eine Schlüsselrolle in der 
Feinabstimmung von Steifigkeit, Festigkeit und Härte des Knochens dar und ist ein 
wichtiger Faktor für die Knochenqualität. Reife trabekuläre und osteonale Knochen setzen 
sich aus einzelnen unterschiedlich mineralisierten Knochenstruktureinheiten (BSU) 
zusammen, die eine charakteristische Knochenmineralisationsdichteverteilung (BMDD) 
erzeugen. Die jungen, neu gebildeten BSU’s sind noch nieder mineralisiert, während die 
alten BSU’s den höchsten Mineralisationsgrad aufweisen. Das genaue Wissen um den 
zugrundeliegenden Mineralisationsprozess ist noch unvollständig.  
Man konnte zeigen, dass der Mineralgehalt in einer neugeformten Knochenmatrix 
(Osteoid) innerhalb von nur wenigen Tagen auf 70% des Endwertes ansteigt, sobald der 
Mineralisationsprozess gestartet wurde. Diesen Vorgang bezeichnet man als primäre 
Mineralisation. Bis die restlichen 30% Mineralgehalt erreicht werden, dauert es dann 
Monate bis Jahre und man bezeichnet diesen Vorgang als sekundäre Mineralisation. In 
dieser Arbeit lag der Fokus auf der Ermittlung des Kalziumgehalts, der den Übergang von 
der schnellen zur langsamen Mineralisation beschreibt. Dieser Punkt wurde von uns als 
CaTURN bezeichnet. Durch diese Analysen könnten Knochenerkrankungen detektiert 
werden, deren Auswirkungen den primären Mineralisationsprozess betreffen, und es 
könnte ein Beitrag zur Entwicklung therapeutischer Strategien, die direkt in den 
Mineralisationsprozess einwirken, geleistet werden.  
Zu diesem Zweck wurden humane Beckenkammbiopsien (n=72) in 
Polymethylmethacrylate eingebettet. Angeschnittene Knochenflächen wurden mittels 
quantitativer Rückstreuelektronenmethode (qBEI) mit einer Bildauflösung von 0,5!m 
Pixelgröße im Rasterelektronenmikroskop untersucht. Für die Analyse wurden BSU’s mit 
einer sichtbaren Mineralisationsfront ausgesucht und im rechten Winkel zur 
Mineralisationsfront quer durch das frisch angebaute Knochenpaket ein 
Mineralisationsdichteprofil (BM-Profil) aufgenommen. Die erhaltenen Diagramme 
konnten durch zwei lineare Fits mit unterschiedlichen Anstiegen dargestellt werden. Der 
Schnittpunkt der beiden Geraden bestimmte den Wert des CaTURN.  
Biopsie-Ergebnisse von Kindern mit der genetischen Erkrankung Osteogenesis 
Imperfecta (OI-Typ I, n=5 and OI-Typ VII, n=4) wiesen einen erhöhten CaTURN-Wert 
gegenüber der Kinder-Kontrollgruppe auf. Im Gegensatz dazu zeigten Kinder mit einer 
autosomal dominanten Hypokalzämie (ADH), einer vererbten Form des 
Hypoparathyreoidismus, die durch eine Mutation am Calcium Sensing Receptor (CaR) 
(n=3) verursacht wird, einen verminderten CaTURN-Wert. Biopsie-Ergebnisse von 
postmenopausalen osteoporotischen Frauen (n=9), behandelt mit Kalzium und Vitamin D, 
hatten einen CaTURN, der sich nicht von der Erwachsenen- Kontrollgruppe (n=8) 
unterschied. Jedoch bei allen PatientInnen mit Knochenerkrankungen unklarer 
Differentialdiagnose (n=10) zeigte sich ein reduzierter CaTURN-Wert. Korreliert man die 
Parameter der Knochenmineralisationsdichteverteilung (BMDD) mit dem CaTURN-
Parameter, so ergab sich beim CaMEAN (BMDD-Parameter) und beim CaPEAK 
(charakteristischer Kalziumgehalt des gesamten spongiösen Knochenkompartiments) eine 
eindeutig lineare Korrelation bei den Kindern mit genetischen Veränderungen während 
innerhalb der Erwachsenen-Patientengruppe keine Korrelation festgestellt wurde.  
Die Ergebnisse zeigen, dass der primäre Mineralisationsprozess bei den 
untersuchten genetisch erkrankten PatientInnen negativ beeinflusst wird, und dass der 
endgültige Kalziumgehalt, den die Knochenmatrix erreichen kann, abhängig vom primären 
Mineralisationsprozess ist. Diese neuen Untersuchungsergebnisse geben Evidenz, dass ein 
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pathologischer Grad der Mineralisierung des Knochens das Resultat eines veränderten 
Knochen-Turnovers und / oder eines veränderten Knochenmineralisationsprozesses sein 
kann.  
Tatsächlich scheinen die Veränderungen im BMDD bei PatientInnen mit genetischen 
Erkrankungen wie Osteogenesis Imperfekta oder Calcium Sensing Receptor Mutationen 
vorwiegend die Folge der Veränderung im primären Mineralisationsprozesses zu sein, 
während die Effekte, die bei den Erwachsenen-PatientInnen gefunden wurden, 
hauptsächlich Folgen der Änderungen im Knochen-Turnover zu sein scheinen. 
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1. INTRODUCTION 
 
I was working for my Thesis on the Ludwig Boltzmann-Institute of Osteology 
(LBIO) under supervision of Univ. Doz. Dipl. Ing. Dr. Paul Roschger (LBIO). The 
LBIO is a multidisciplinary research institute for bone, embedded in a clinical 
network at the Hanusch Hospital of WGKK and the AUVA Trauma Centre 
Meidling in 1140 Vienna and 1120 Vienna, respectively (www.osteologie.at). 
The primary goal of the Institute is the improvement of patient care. For this 
purpose, the study of bone, a highly complex hierarchical organized structure, is 
undertaken at all hierarchical levels. Especially, the quality of bone is 
addressed, which is contributing to the mechanical performance of bone.  
 
 
1.1. Objective and Scope of the Thesis 
 
Humans as all vertebrates have a skeletal system comprised of bone, a 
material with outstanding mechanical properties. However, disorders affecting 
the structure and material of bone, leads to enhanced fractures, which are 
associated with elevation in morbidity, mortality, loss of life quality and high 
socioeconomic costs. The increase in life expectancy for the population is the 
main factor today causing a remarkable increase in fracture incidence. Thus, 
the estimation of the bone fracture risk of a patient is the essential goal for 
correct treatment decisions for clinicians to prevent fractures and a challenge 
for material scientists. Only on the basis of an appropriate fracture risk 
assessment a high fracture risk can be diagnosed and the patient can get the 
correctly targeted treatment. Further, the success of a therapy can be 
evaluated. To date the prediction of fracture risk is mainly based on non 
invasive measurements like bone mineral density (BMD) or mineral content 
(BMC - a measure of the total mineral mass) as measured by dual energy x-ray 
absorption analysis (DXA) and biochemical bone markers in the serum and 
urine. However, only about 50% of the fracture risk in osteoporosis the most 
common skeletal disorder can be explained by these diagnostic tools (Marshall 
et al. 1996). The reason for this limitation is, that the total bone mass (bone 
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quantity) alone does not determine the fracture risk but additionally, the quality 
of the bone material contributes essentially to bone strength (Bouxsein 2003; 
Fratzl et al. 2004a; Seeman 2008). Generally, there are three levels at which 
the deterioration of the mechanical properties of a bone may occur: 
 
1) the amount of bone material  
2) the quality of bone architecture   
3) the quality of bone material  
 
Beside the amount of bone material (1) it was found that e.g. the trabecular 
architecture (2) such as connectivity, orientation, etc. in cancellous bone and 
geometrical properties of cortical bone such as outer diameter, thickness and 
porosity etc. have a significant influence on the mechanical integrity. Finally, 
alterations in the quality of the material (3) the trabecular and cortical motifs are 
composed of can play a pivotal role in loosing the mechanical competence of 
the whole bone. Important determinants of bone material quality (3) are the 
properties of the collagen/mineral nano-composite material like, particle density, 
size, shape, as well as the arrangement of mineral particles and the fibrillar 
collagenous matrix. In contrast to clinical BMD measurements, the assessment 
of bone trabecular architecture and aspects of bone material quality cannot be 
done in vivo, but needs a bone biopsy and a combination of modern physical 
techniques.  
 
At the LBIO, the material level of bone is approached in a multidisciplinary way 
by a worldwide unique combination of modern physical techniques including a 
long-term collaboration with the Max Planck Institute of Colloids and Interfaces, 
Dept. of Biomaterials Potsdam/Germany (Director: Prof. Dr. Peter Fratzl). 
Quantitative backscattered electron imaging (qBEI) (Roschger et al. 1995; 
Roschger et al. 1998; Roschger et al. 2008b) is employed to assess the mineral 
content spatially resolved within the bone matrix, which is crucial for the elastic 
properties of the bone material. In combination with confocal laser scanning 
microscopy (CLSM) the dynamics of bone mineralization are determined. 
Polarized light microscopy (pLM) allows to visualize the lamellar arrangement of 
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collagen fibrils in trabecular and osteonal bone compartments. The 
arrangement of the fibrils plays a pivotal role in resistance to crack propagation 
and thus in bone strength. Fourier transform infrared microspectroscopy (FTIR) 
(Paschalis et al. 2001) and RAMAN (Kazanci et al. 2007) (are applied to 
characterize the chemical bonds in the collagen/mineral composite. Especially 
the collagen cross-link status modifies the mechanical properties of the 
composite. Scanning small angle x-ray scattering (sSAXS) (Rinnerthaler et al. 
1999) is used to determine important bone composite parameters like mineral 
particle thickness, orientation, arrangement and inter-particle distance. The 
application of the nanoindentation technique on the atomic force microscope 
(AFM) (Gupta et al. 2005) enables us to make mechanical testing experiments 
of the bone material with about a 5!m spatial resolution. Parameters, like E-
modulus and hardness are evaluated from each indentation experiment and are 
correlated with other composite parameters. 
 
 
1.2. Aim of the Thesis 
 
The bone material / matrix is a fiber nanocomposite of carbonate hydroxyapatite 
mineral and collagenous fibers. The degree of bone matrix mineralization is 
playing a pivotal role in tuning stiffness, strength and toughness of bone and is 
therefore an important determinant of bone quality. On one hand deficiency in 
mineral content leads to a less stiff bone and deformation occurs like in rachitic 
(Vit D deficient) patients (Lips et al. 2009). On the other hand hypermineralized 
bone matrix like osteogenesis Imperfecta (OI) leads to a brittle bone (glas bone) 
and the patients suffer on multiple fractures (Marini 2006). 
 
Each individual has its characteristic bone mineralization density distribution 
(BMDD) like a fingerprint (Ruffoni et al. 2007; Roschger et al. 2008b). It is 
generated by the fact that bone is a living system, which is continuously 
destructed and renewed by bone cells the so called multicellular units (cycles of 
remodeling) forming basic structural units (BSUs), bone packets in trabecular 
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and osteons in cortical bone. Two independent processes are responsible, 
which lead to a specific BMDD (Fig. 1): 
 
1) The frequency of bone remodeling, which leads to a certain 
       bone turnover rate. 
 2) The time course of mineralization (the mineralization law) of  
       newly apposed bone matrix (osteoid)   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Schematic drawing of the generation of specific BMDDs. Two processes are 
responsible for its shape: bone remodeling and mineralization kinetics of bone matrix. 
Remodeling leads to the formation of non-mineralized bone packets (osteoid), which 
are mineralized following a certain mineralization law (describing the increase in Ca-
concentration with time, see top right). The mineralization law shows an initial fast 
(primary mineralization) phase followed by a slow (secondary mineralization) phase of 
increase in mineral content. In consequence, a mosaic like structure of bone packets 
with different mineral content corresponding to the different tissue age (middle left and 
right) is generated. The effect of three different scenarios on the BMDD is sketched 
(bottom): (1+A) normal turnover and normal mineralization; (2+A) high turnover and 
normal mineralization; (1+B) normal turnover and altered mineralization (after: Nawrot-
Wawrzyniak et al. 2009). 
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The exact knowledge of the underlying mineralization process is still lacking, but 
it could be shown that once mineralization has started in the newly formed bone 
matrix, the mineral content is rapidly increasing within few days up to 70 % of its 
final value and is referred as primary mineralization. The last 30% of increase in 
mineral content occurs only slowly in a time scale of month to years and is 
referred as secondary mineralization (Boivin and Meunier 2002; Misof et al. 
2003). This biphasic kinetic of mineralization of bone has also been confirmed 
by mathematical (computed) modeling of the BMDD (Ruffoni et al. 2007; Ruffoni 
et al. 2008). In consequence of bone turnover and mineralization kinetics, 
mature trabecular and osteonal bone is composed of differently mineralized 
bone packets (bone structural units (BSUs)) generating a characteristic bone 
mineralization density distribution (BMDD). Young BSUs have the lowest and 
old BSUs the highest degree of mineralization. 
 
Generally, bone diseases can affect process one (1) (bone turnover) and/or 
process two (2) (mineralization). Both can lead to similar deviations from normal 
BMDD. For instance high bone turnover would shift the BMDD towards lower 
mineralization (Fig. 1), however the same can happen, if the mineralization law 
is changed leading to lower mineralization at normal bone turnover. Thus it is 
from high clinical interest to know which disorder the patient is presenting to 
chose the correct therapeutic strategy. High bone turnover would usually be 
treated by antiresorptive drugs while in cases of deficiency in mineralization 
other therapeutic strategies have to be applied or developed first.  
 
The present thesis focuses on transiliac biopsies of patients with a broad 
spectrum of metabolic and genetic bone diseases. We used the qBEI method 
for the first time to determine the Ca-content at the transition from fast to slow 
mineralization, which had been designated by us as CaTURN (Roschger et al. 
2008b). A further tool of differential diagnosis in bone diseases, new insights 
into normal and pathological mineralization processes and help in the 
development of new drugs targeting directly the mineralization process can be 
expected. 
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2. CHARACTERISTICS OF BONE 
 
The germ layer mesoderm in the early embryonic stage is the origin of the 
development of all the skeletal tissues components. The mesoderm 
differentiates into cells producing connective tissue, including bone, cartilage, 
dentin as well as cementum. Only dental enamel is generated by cells coming 
from another germ layer, the ectoderm (Ortner and Turner-Walker 2003). Bone 
constitutes the largest proportion of connective tissue mass in the human body. 
Unlike most other connective tissue matrices, it is mineralized and constantly 
regenerated throughout life. Bone as an organ is composed of the cortical and 
trabecular bone, the bone marrow, the cartilaginous joints, and the growth plate 
in developing individuals. Approximately 65wt% of the tissue consists of 
mineral, water comprises about 5 to 8wt% and the rest is made up of 
extracellular matrix or organic material. Nearly 95wt% of the mineral phase 
consists of carbonated hydroxyapatite. About 90wt% of the organic phase 
consists of type I collagen and 10wt% as a variety of non-collagenous proteins 
and proteoglycans. The absolute amounts of these constituents vary with age, 
sex, tissue site, health and dietary status (Urist 1980). 
 
Bone as living material has outstanding mechanical properties forming the 
skeletal system together with cartilage and fulfills three important functions:  
 
1) mechanical support, movement 
2) protection of internal organs and bone marrow  
3) metabolism, as a reservoir of calcium- and phosphate ions  
   (Cashman 2002)  
 
The biomaterial bone is characterized by its complex hierarchical structure, 
which is essential for its extraordinary biomechanical properties. Each level of 
structural organization has to be optimized to achieve the overall optimal 
mechanical performance of bone at organ level. (Paris et al. 2000; Roschger et 
al. 2008b).  
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2.1 Hierarchical Structure 
 
 
Figure 2: The hierarchical organization of bone structure. The strength of bone is the 
product of structural optimization at each level of bone structure. 
 
 
 
2.1.1. Collagen and Mineral (level 0) 
 
Bone is a nano-composite material composed at the lowest nanostructural level 
of mineral (carbonated hydroxyapatite Ca10(PO4)6(OH)2 and collagenous 
(mainly collagen type I) and non-collagenous organic proteins. 
 
Collagen: The collagen is synthesized as procollagen first within the 
osteoblasts. Two !1-chains and one !2-chain are synthesized and the chains 
are intertwined to form a triple helix, whose amino acid sequence consists of 
Gly-X-Y repeats, each with a length of about 1400 residues. In about one-third 
of the cases, X is a proline and Y is a hydroxyproline. The presence of 
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hydroxyproline is essential, as it stabilizes the triple helix and is a unique 
characteristic of collagen molecules (Bilezikian et al. 1996). The triple helix of 
the procollagen has propeptide extensions at both N- and C-terminals. After 
excretion outside the osteoblasts, enzymatic cleavage converts the procollagen 
to collagen and the helical molecules assemble spontaneously into collagen 
fibrils. Collagen can stretch like an elastic band and allows bone to deform to a 
certain extent without fracturing. The flexibility of collagen can be altered due to 
chemical changes, thus reduces the toughness of bone and increases its 
fragility (Paschalis 2006) (Vashishth et al. 2001). Collagen diseases can be 
commonly attributed to genetic defects, which are affecting the biosynthesis, 
assembly, posttranslational modification, secretion, or other processes in the 
normal production of collagen. Collagen abnormalities and altered cross-link 
profiles are associated with osteoporosis (McLean et al. 2004; Blouin et al. 
2009) , osteopetrosis (Wojtowicz et al. 1997) and osteogenesis imperfecta 
(Prockop et al. 1989; Kuivaniemi et al. 1991).  
 
 
 
Mineral: The inorganic constituent of bone comprises poorly crystalline 
hydroxyapatite with the stoichiometric formula Ca10(PO4)6(OH)2 among others 
crystal lattice substitutions like carbonate, fluoride, citrate and potassium. The 
crystals are platelets or spicules, have a thickness of 2 to 4 nm and a width and 
length of tens of nanometers (Fratzl et al. 2004a). The crystal lattice spacing 
along a and b axis is 0.9432 nm and of the c-axis of the hexagonal lattice (the 
long axis) spacing is 0.8881 nm (Veis 2003) (Burger et al. 2008). Depending on 
the crystals’ maturation, various amounts of carbonate ions are incorporated in 
the crystals lattice leading to carbonated apatite (Legros et al. 1987; Fratzl et al. 
2004a). The crystal size, shape and thickness is a determinant of intrinsic bone 
material properties /quality of the collagen mineral composite. Thus alterations 
in mineral particles size, as it was observed in osteoporotic patients with fluoride 
treatment, was the reason that despite the increased formation of new bone this 
treatment failed to have any beneficial effect to fracture risk. Obviously the 
mechanical competence of the bone matrix formed under sodium fluoride (NaF) 
treatment was deteriorated (Fratzl et al. 1994; Roschger et al. 1997). 
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Figure 3: Level 0 - collagen molecule and mineral (carbonated apatite):  
A) collagen type I: a) large protein with a highly repetitive amino acid sequence based 
on -Gly-X-Y- (Gly = glycine, X = proline, Y = hydroxyproline). Every third residue is Gly. 
(b) Gly is the smallest amino acid where the residue is just a hydrogen atom. (c) The 
collagen type I molecule is formed a triple helices, which are composed of two !1 and 
one ! 2 chains. 
(d) Proline and hydroxyproline have residues connecting back to the polypeptide chain. 
(after: Fratzl and Weinkamer 2007). 
B) Mineral: hydroxyapatite = Ca10(PO4)6(OH)2, depending on crystal maturation various 
amounts of carbonate ions are incorporated in the crystal lattice in exchange with PO4
- 
or OH- leading to carbonated apatite. 
 
 
 
Techniques used for analysis at collagen and mineral level: 
• Small-Angle X-ray Scattering (SAXS) 
• Wide Angle X-ray Scattering (WAXS) 
• Fourier-Transforming InfraRed microspectroscopy (FTIR) 
• Raman spectroscopy (Raman) 
• Energy Dispersive X-ray spectroscopy (EDX) 
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2.1.2. Mineralized Fibril (level 1) 
 
The mineralized collagen fibril is the basic building block of bone. The collagen 
fibrils are formed in the extracellular space by processes of self-assembly. The 
intertwined collagen molecules (two !1 chains and one !2 chain) form a triple-
helical molecule of ~300 nm in length and ~1.5 nm in diameter. The collagen 
triple helices molecules form fibrils (Fratzl et al. 2004a), in which the single 
molecules lay parallel with a displacement of 67 nm between them in a 
staggered array, stabilized by intermolecular cross-links. Thereby hole zones of 
35 nm and the overlap zones of 32 nm length are generated within the fibril 
leading to a banded structure. Many collagen fibrils together form a collagen 
fiber. The intra- and inter- fibrillar molecular cross-links play thereby a pivotal 
role for the mechanical strength of the mineralized fibrils. 
 
The collagen fibril is reinforced by small nano-sized mineral particles, plate-like 
mineral crystals of carbonated hydroxyapatite. They are aligned with their c-axis 
parallel to the longitudinal axis of the collagen fibrils. Most likely they are also 
arranged in a staggered way (as this arrangement is most useful for mechanical 
performance), so that the mineral platelets overlap in the hole zones of the fibril. 
By this way a nano composite material is formed combining two mechanical 
properties of the individual components, collagen - soft and tough - and mineral 
- stiff and brittle - to a material which has both properties - stiff and tough 
(Ashby 1983; Fratzl 2006). Thus, mineral dictates much of the tissue stiffness 
and collagen has a profound effect on bone’s post-yield properties, e.g. energy 
absorption (Burr 2002). 
  
Important contributions to the fracture resistance and defect tolerance of bone 
composites arise from the nanometer scale. It was shown, that mineral 
nanoparticles and the mineralized fibrils deform both first elastically, but to 
different degrees, in a ratio of 12:5:2 between tissue, fibrils and mineral particles 
(Fig. 4). The different degrees of deformation of different components arranged 
in a parallel and staggered way within the tissue can be explained by a shear 
deformation between the components (Jager and Fratzl 2000) This means that 
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there is a shear deformation within the collagen fibrils making the difference 
between the strain in collagen and mineral possible. However, there must also 
be some shear deformation between adjacent collagen fibrils to accommodate 
the different strains in fibrils and the entire bone tissue. This shear deformation 
occurs presumably in a thin “glue” layer between fibrils in bone. They may 
consist of proteoglycans and non-collagenous phosphorylated proteins (Fratzl 
and Weinkamer 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Level 1 – mineralized collagen fibrils:  
A) Sketch of arrangement of staggered collagen molecules with embedded 
plate-like mineral crystals.  
B) Mechanical model of deformation mechanism: The tensile load is transferred 
to all the mineral particles by shear forces generated in the collagen matrix 
functioning as glue. The same principle is working between the staggered 
arrangements of the mineralized fibrils and the inter-fibrilar matrix at the next 
higher hierachical level (Jager and Fratzl 2000; Fratzl et al. 2004a; Fratzl et al. 
2004b; Gupta et al. 2006) 
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Techniques used for analysis at fibril level: 
• Scanning Small-Angle X-ray Scattering (SAXS) 
• Scanning x-ray diffraction (XRD)  
• Transmission Electron Microscope (TEM) 
• Atomic force microscopy (AFM) 
 
2.1.3. Arrangements of Fibrils / lamellae (level 2) 
 
The basic building blocks of bone, the mineralized fibrils, are mostly aligned in 
bundles or arrays. They form various patterns and build the final material of the 
tissue motifs, like trabecular and osteonal bone, primary periosteal bone, 
membranous bone, plexiform bone, callus, dentin, mineralized turkey leg 
tendon etc.. The pattern of fibril arrangement is highly responsible for the 
anisotropy in mechanical properties found in bone tissue. Indeed, a crack 
propagation perpendicular to the longitudinal axis of the collagen fibril bundle 
needs of two orders more energy than parallel to fibril axis (Peterlik et al. 2006) 
(Fratzl and Weinkamer 2007).  
 
DIFFERENT PATTERNS OF FIBRIL BUNDLE ARRANGEMENTS ARE DISTINGUISHED: 
WOVEN BONE: Fibrils are arranged in loosely packed and randomly oriented 
bundles with different diameters. It contains also a large proportion of non-
collagenous material. It is built very quickly, e.g. the embryonic and/or fetal 
skeleton and in the callus after a bone fracture. 
  
PARALLEL-FIBRILAR PATTERN: The fibrils and fibres are predominantly oriented 
parallel to each other and roughly parallel to the long bone axis. This is the case 
in cortical long bone of mouse, rats. Extreme amount of parallel arranged fiber 
bundles can be found in turkey leg tendons.  
 
ROTATED PLYWOOD-LIKE STRUCTURE OF LAMELLAR BONE: This is the most common 
matrix structure of mature human bone of trabecular bone packets and cortical 
osteons. In trabecular bone the lamellae are aligned parallel to the trabecular 
surface. In osteonal bone the lamellae are arranged in concentric rings around 
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the haversian canal. The arrays of collagen fibrils orientation is changing in a 
regular manner to form a complex rotated plywood-like structure having a 
typical lamellar unit of approximately 5!m in thickness, in which the changing of 
the predominant fibril orientation is completed once. In polarized light 
microscopy the lamellar arrangement becomes visible by alternating contrast 
bright and dark. This type of bone matrix is formed more slowly than woven or 
parallel fibred bone.  
 
RADIAL FIBRILAR PATTERN: This pattern is characteristic of the bulk of dentin, 
which forms the inner basis of the teeth. The collagen fibrils are arranged in 
plane randomly oriented perpendicular to the longitudinal axis of tubular canals.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Level 2 – lamellar arrangement of collagen fibrils: Polarized light 
microscopy (pLM) visualizes the changing orientations of collagen fibrils 
between the lamellae of trabecular bone. 
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Techniques used for analysis at lamellar level: 
• polarized-Light Microscope (p-LM) 
• Raman Microscopy 
• Scanning Small angle X-ray scattering (scanning-SAXS) 
 
 
2.1.4. Bone Structural Units (BSU) (level 3) 
 
The trabecular and cortical bone motifs are composed by BSUs. BSU denotes a 
unit bone matrix, which is formed during a complete remodeling cycle by one 
bone multicelluar unit (BMU). In trabecular bone it is called bone packet and in 
cortical bone osteon. Characteristically, they have a lamellar bone structure with 
a uniform lamellar orientation and a certain rather uniform mineral content. 
Adjacent BSU are separated by cement lines / surfaces, a non collagenous 
protein (NCP) rich mineralized matrix built by the BMU. 
Since the mineral content in the BSU is increasing with time, the mineral 
content of a single BSU in an individual depends on the time passed after its 
formation. Therefore, the mineral content between the BSUs can vary between 
0 to 65wt %. Thus, a bone tissue exhibits a characteristic pattern due to the 
different ages of BSUs, which can be quantified as mineralization density 
distribution (BMDD) (Roschger et al. 2008b). Hence, the BMDD is also 
reflecting rather the actual tissue age than the age of the individual. Further, the 
mineral content is tuning the stiffness, toughness and strength of the bone, so 
that the BMDD is an important factor in determining the bone material quality. It 
was found that the BMDD of healthy adults exhibited relatively small variations 
independent of skeletal site, gender, age and ethnic origin (Roschger et al. 
2003) representing most likely an evolutionary optimum. Hence, already small 
deviations caused by diseases might be of biological relevance for an increase 
of fracture risk in the patient. For instance diseases like osteoporosis are 
associated mostly with an increased bone turnover, which means that the 
frequency of bone remodeling sites is increased. This leads to an elevation of 
younger BSUs with lower mineral content. Such a BMDD is shifted towards 
lower mineralization density compared to normal. 
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Figure 6: Level 3 - trabecular bone packets: Quantitative backscattered electron 
images (qBEI) showing bone packets (BSUs) of different mineral content 
reflecting their different tissue age. Dark gray new bone packets low with 
mineral content, light gray old bone packtes with high mineral content. White  
lines between the packets are highly mineralized cement lines. (Source: LBIO) 
 
 
Techniques used for analysis at BSU level: 
• quantitative Backscattered Electron Imaging (qBEI) 
• Microradiography (MR) 
• Synchrotron Radiation Micro Computer Tomography (SR-!CT) 
• Electron induced X-ray Fluorescence Energy Dispersive X-ray analysis  
 (ERF-EDX) 
• Synchrotron induced X-ray Fluorescence micro Computer Tomography 
 (SR-XRF !CT)  
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2.1.5. Bone Tissue / Trabeculae and Osteons (level 4) 
 
The mature human bone tissue appears with two types of inner bone 
architecture, the cancellous and the cortical / compact bone, made by the BSUs 
as a result of a modeling and remodeling process throughout the entire lifetime 
of an individual. Cancellous bone is formed by plate and rod like trabecular 
features and forms a spongy like structure with a high porosity (>70%). The 
thickness of the struts in trabecular bone is fairly constant between one and 
three hundred micrometers (Fratzl and Weinkamer 2007) (Parisien et al. 1988; 
Han et al. 1996)  
 
The trabeculae are interconnected in a honeycomb pattern, thereby providing 
maximum mechanical strength and ensuring resistance to compression 
stresses (Eriksen et al. 1994). Trabecular bone makes up the vertebral body 
and in the epiphyseal and metaphyseal region of long bones. 
 
Cortical or compact bone is composed by osteons or haversian systems 
consisting of bone lamellae arranged in concentric layers along the long axis 
that surround a central canal containing nerves and blood vessels. The porosity 
of cortical bone is less then 10%. The cortical bone shell can reach a thickness 
between several tenths of a millimeter e.g. in vertrebrae, to several millimeters 
or even centimeters e.g. in the diaphysis of long bones. Cortical bone accounts 
for nearly 80% of the skeletal mass (Stein et al. 1999) and fulfills mainly 
protective and mechanical functions. It allows the body to withstand the forces 
of tension, torsion and compression due to its tight network-like structure of 
osteons. 
 
Techniques used for analysis at tissue level: 
• Light Microscopy (bright field, polarized light, fluorescence light), 
histological staining, tetracycline double labeling; 
• quantitative Backscattered Electron Imaging (qBEI) 
• Microradiography 
• X-ray Micro Computer Tomography (!CT) 
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Figure 7: Level 4  – cortical and cancellous bone: 
Longitudinal section of proximal human femur as overview and as details in higher 
magnification by backscattered electron imaging A) Cortical / compact bone: composed 
by osteons (central haversian canal surrounded by cylindrical arranged lamellar bone) 
and interstitial bone (old residual bone matrix). Structural parameters: porosity (<30%), 
Ct.Wi.= cortical width (~1mm) B) Trabeculae of cancellous bone (spongiosa). Structural 
parameters: BV/TV= bone volume per tissue volume (<70%), Tb.Th.= trabecular 
thickness (~120 !m), Tb.N.= trabecular number (~1.6/mm), Connectivity= degree of 
connection between trabeculae. (Source: LBIO) 
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2.1.6. Whole Bone (level 5) 
 
In the human skeleton between three different shapes/types of bone can be 
distinguished:  
 
1) Plate-shaped bones like skull bones, scapula, mandible and ilium;  
2) Long bones like tibia, femur, humerus, etc.;  
3) Short bones, like wrist, ankles and vertebrae.  
 
The shape, outer geometry, size and inner architecture of these bone types are 
the result of embryonal bone development based on a combination of 
intramembranous and endochondral ossification. The bones are designed in 
strong relation to their mechanical function under the rule to achieve a 
maximum on strength with a minimum usage of bone material. Thus, flat bones 
consist of two compact bone layers, sandwiching a zone of cancellous bone in-
between making a stiff and strong plate to protect e.g. the sensitive brain by the 
scull. The long bones of the human skeleton, such our limbs are built as tubes 
to withstand best the bending stress caused by different movements. The short 
bones like vertebrae are connected to form the spinal column. The thin cortex is 
filled with cancellous bone to make these bone not to heavy, but still can 
withstand high compression loads. Additionally, intervertebral cartilage disks act 
as shock absorber between the vertebrae.  
 
 
Techniques used for analysis at organ level: 
• Radiography 
• Dual Energie X-ray Absorption (DXA) 
• X-ray Computer Tomography (CT) 
• peripheral quantitative Computer Tomography (pqCT) 
• Nuclear Magnetic Resonance Imaging (NMR) 
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Figure 8: Level 5 - Wohle bone (geometry, shape, size): 
The three different bone shapes: long bones e.g. femur; short bones e.g. vertebra;. 
plate-like bones e.g. skull. 
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2.2. Bone Cells 
 
For the development and maintenance of bone essentially four different types of 
cells are engaged. The osteoblasts, the osteoclasts, the bone lining cells, which 
all are located on bone surfaces (inner and outer) and the osteocytes, which 
permeate the mineralized interior of the bone matrix (Marks and Hermey 1996). 
The main function of the osteoblasts is the production of new extracellular 
matrix, its apposition on the surface of bone motifs (trabeculae and haversian 
canals) and its controlled mineralization. The lining cells, which are covering the 
entire quiescent bone surface, are thought to control the access to the pure 
bone matrix at the bone surface, which is important for Ca-homeostasis and 
attachment of osteoblasts and osteoclasts. The osteoclasts are responsible for 
resorbing old bone matrix. The osteocytes are dispersed throughout the 
mineralized matrix and are interconnected to a network. It is assumed that they 
play a pivotal role in mechanosensing and Ca, P, homeostasis. In the adult 
skeleton, the osteocytes make up >90-95% of all bone cells compared with 4-
6% osteoblasts and "1-2% osteoclasts Bone (Bonewald and Johnson 2008) 
.The bone cells, which are responsible for bone formation, -repair and -
remodeling respond to hormonal, mechanical and other extrinsic signals. 
Osteoblasts, osteocytes and bone lining cells originate from mesenchymal stem 
cells of the bone marrow, which differentiate over osteoprogenitor cells to 
preosteoblasts and then to mature osteoblasts. Osteoclasts originate from 
hematopoietic stem cells, which differentiate over mononuclear precursor cells 
to preosteoclasts and subsequently to multinucleated active osteoclasts. 
 
2.2.1 Osteoblasts 
 
Osteoblasts are large cuboidal cells (20 - 30 !m), responsible for the formation 
of osteoid, the unmineralized collagenous matrix of bone tissue (Fig. 9). 
Osteoblasts contain the normal basic ingredients of a cell – a single nucleus, 
endoplasmatic reticulum, well-developed Golgi bodies and numerous ribosomes 
and mitochondria – reflecting the requirement for abundant protein synthesis in 
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osteoid formation. These proteins include pro-! collagen (a basic component of 
collagen), osteocalcin (OC) and bone morphogenic protein (BMP). When 
human osteoblasts have completed their matrix forming function after an 
average lifespan of 1 to 10 weeks, approximately 50-70% die by apoptosis and 
15% become transformed into bone lining cells or into osteocytes (Aubin and 
Liu 1996; Dempster 2006; Fernandez-Tresguerres-Hernandez-Gil et al. 2006a) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Light microscopic (LM) image of detail from trabecular bone: undecalcified 
bone section (3 !m thick) stained by Trichrome Goldner staining; white arrows indicate  
osteoblasts; white star designates the unmineralized osteoid seam (orange); 
mineralized bone (green).(Source: LBIO) 
 
 
Cytokines which are involved in osteoblast differentiation are the Hedgehogs 
(Hh), bone morphogenic proteins (BMPs), transforming growth factor beta 
(TGF-!), parathyroid hormone (PTH) and WNTs. The activation of the 
transcription factor Runx2 (also known as Cbfa1) is a point of convergence of 
many involved signal transduction pathways. Runx2 is a master switch for 
osteoblast differentiation and regulate Osterix, a zinc finger-containing 
transcription factor, which is essential for bone formation.  
Differentiation markers of osteoblasts are alkaline phosphatase (ALP), type I 
collagen (Col1), bone sialoprotein (BSP), osteopontin (OPN) and osteocalcin 
 
 
 22 
(OC). ALP is used as an early marker, whereas OC is a late marker for 
osteoblast differentiation (Ortner and Turner-Walker 2003) (Krause et al. 2008).  
 
The osteoblasts and the osteocytes communicate with each other by 
transmembran proteins or integrins, which act as a link between cells or 
between a cell and the extracellular matrix, allowing the passage of messengers 
such as calcium, cytokines and prostaglandins. In these cells the intercellular 
connection is Connexin 43.  
 
The osteoblast functions are: 
• synthesize the collagen and non-collageneous proteins of the 
organic bone matrix,  
• direct the arrangement of the extracellular matrix fibrils, 
• contribute to the mineralization of the osteoid material, due to  
alkaline phosphatase, 
• mediate in the resorption carried out by the osteoclasts through 
the synthesis of specific cytokines and  
• synthesize growth factors (Fernandez-Tresguerres-Hernandez-Gil 
et al. 2006a). 
 
2.2.2 Osteoclasts 
 
The osteoclast is a giant multinucleated bone resorbing cell, up to 100 !m in 
diameter with abundant mitochondria, numerous lysosomes and ribosomes. It 
derives from hematopoietic precursors of the monocyte/macrophage lineage. 
They are formed through fusion of mononuclear cells (Teitelbaum et al. 1997; 
Parfitt 1998; Teitelbaum and Ross 2003). 
 
A large group of cytokines and colony-stimulating factors are involved in 
hematopoiesis and osteoclast development (Manolagas et al. 1996). This group 
includes the interleukins IL-1, IL-3, IL-6, IL-11, leukemia inhibitory factor (LIF), 
oncostatin M (OSM), ciliary neurotropic factor (CNTF), tumor necrosis factor 
(TNF), granulocyte macrophage-colony stimulating factor (GM-CSF), M-CSF 
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and c-kit ligand. As opposed to the previously mentioned cytokines they 
stimulate osteoclast development, IL-4, IL-10, IL-18 and interferon-" inhibit 
osteoclast development (Manolagas 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10: Secondary electron imaging in SEM of bone resorbing osteoclast with 
generation of resorption pits (resorption lacunae) 
(Source: http://www.cdb.ucl.ac.uk/research/arnett/arnett_lab/index.html) 
 
 
Mature osteoclasts are characterized by the presence of a ruffled border, which 
consists of a complex infolding of plasma membrane and a prominent 
cytoskeleton. Osteoclasts have abundant Golgi complexes, abundant 
mitochondria and transport vesicles loaded with lysosomal enzymes. The key to 
the resorption process is the capacity of the osteoclast to form a 
microenvironment between itself (ruffled border plus sealing zone) and the 
underlying bone matrix. This compartment is acidified by H+-ATPase, an 
electrogenic proton pump and a chloride channel to a pH of ~4,5. The acidified 
milieu releases the mineralized constituent of bone, the hydroxyapatite, and 
exposes the organic bone matrix, mainly collagen type I, that is subsequently 
degraded by the lysosomal enzyme cathepsin K. The bone degradation 
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depends on physical intimacy between osteoclast and bone matrix (sealing 
zone) provided by integrins. Integrins are the principal cell/matrix attachment 
molecules, which mediate osteoclast/bone recognition (Ross 2008) (Hadjidakis 
and Androulakis 2006). After the resorption phase the osteoclasts detach itself 
from the bone resorbing surface and apoptosis occurs (Ortner and Turner-
Walker 2003). The average lifespan of human osteoclasts is about 2 to 6 weeks 
(Frost 1963).  
 
Coupling of osteoclast and osteoblast action: The number of osteoclasts and 
that of the osteoblasts have to be coupled to achieve the correct balance 
between bone formation and resorption. The osteoblasts are fundamental to the 
formation of osteoclasts because the macrophage colony-stimulating factor (M-
CSF) produced by the osteoblasts is required in the early phases of 
osteoclastogenesis for the formation of giant multinucleate cells. The osteoclast 
differentiation from hematopoietic progenitor cells depends on activation of a 
receptor, called RANK (receptor activator of NF#B signaling), consistent with 
evidence that transcriptional regulation by NF#B is important for osteoclast 
development. Osteoblasts express on their surface RANKL, the ligand for 
RANK, a transmembran cytokine belonging to the TNF-family. The interaction 
between RANKL and its receptor RANK initiates osteoclastic activity and 
differentiation and increasing resorption. The effects of RANKL are inhibited by 
osteoprotegerin (OPG) a circulating protein belonging to the superfamily of TNF 
receptors. When OPG and RANKL bind together, the union between RANK and 
RANKL is inhibited and thus the osteoclastic differentiation is also inhibited. 
This shows that OPG, RANK and RANKL are important regulators of 
osteoclastogenesis (Fernandez-Tresguerres-Hernandez-Gil et al. 2006a) (Blair 
et al. 2007).  
Most therapies for osteoporosis targeting inhibition of osteoclastic activity such 
as estrogens, selective estrogen receptor modulators (SERMs), 
bisphosphonates and calcitonin, are anticatabolic. They reduce bone loss by 
inhibiting bone resorption and bone remodeling. 
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Figure 11: RANK Ligand (RANKL) is the primary mediator of the osteoclast formation, 
function and survival. A) OPG/RANKL ratio is low B) OPG/RANKL ratio is high. (After: 
Boyle et al. 2003). 
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2.2.3 Osteocytes 
 
Some osteoblasts (15%) become trapped within the matrix and are transformed 
into osteocytes, when the bone matrix is mineralized. Therefore the osteocytes 
are located in the interior of the bone matrix. They are smaller than osteoblasts, 
but they have numerous dentritic cell processes. Protein-forming organelles are 
reduced, because they are not involved in matrix formation (Ortner and Turner-
Walker 2003). The osteocytes comprise approximately 90% of all cells in 
mature bone (10 times the percentage of osteoblasts), they live in almond-
shaped cavities / lacunae within the bone matrix, from which small channels, 
the so-called canaliculi are running radial into matrix carrying cytoplasmic 
extensions. A single osteocyte may typically have 50 – 70 such canaliculi. This 
network of canaliculi also permits the transport of nutrients, waste products and 
chemical signals between blood vessels and bone cells. They form a huge 
internal bone surface of 5.000 m2, which is believed to have an important role in 
the calcium and phosphorus homeostasis. Recently, it has been established 
that they have an important function in the regulation of phosphate 
homeostasis. Therefore the osteocyte network may also function as an 
endocrine gland (Bonewald 2008). Osteocytes may live for several years before 
being replaced as part of the normal mechanism of bone remodeling (Ortner 
and Turner-Walker 2003) which may in some instances be stimulated by 
osteocyte apoptosis (Fernandez-Tresguerres-Hernandez-Gil et al. 2006a). 
 
The control of bone remodeling, via detecting the mechanical variations of the 
loads, designated as mechanotransduction is believed to be crucial function of 
the osteocytes. The Sclerostin (SOST) gene encodes a protein, which is 
exclusively expressed in osteocytes in mineralized cortical and cancellous 
bone. SOST is a key regulator of bone formation (Lowik and van Bezooijen 
2006; ten Dijke et al. 2008). The loss-of-function mutations of the SOST gene in 
humans were associated with sclerosteosis due to high bone mass. Bone 
biopsies from sclerosteosis and Van Buchem patients showed many more 
cuboidal osteoblasts than the normal control, which may be caused by 
increased Wnt signaling. SOST seems to be a negative regulator of osteoblast 
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development and bone formation. In vitro, SOST was found to inhibit BMP-
induced osteoblast proliferation and differentiation, to suppress mineralization 
by osteoblastic cells and to stimulate osteoblast apoptosis. The SOST effects 
may exert by opposing the action of growth factors like BMP’s and Wnts. The 
inhibition of SOST expression is an ideal candidate for a therapeutic agent. 
Patients with low bone mass, such as osteoporosis, SOST inhibition would lead 
to variable increases in bone mass without any unwanted skeletal effects (ten 
Dijke et al. 2008).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 12: Light microscopic (LM) image of osteocytes network in the mineralized bone 
matrix (source: www.siumed.edu)..  
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2.2.4 Lining Cells 
 
The quiescence bone surface is covered by a 1-2 !m thick layer of 
unmineralized collagen matrix, on top of which there is a layer of elongated and 
flat cells, called lining cells with spindle shaped nuclei and scarce organelles 
(Manolagas 2000). They can express osteoblastic markers such as bone 
sialoprotein, osteopontin, osteonectin and alkaline phosphatase, as well as 
parathyroid hormone receptor. 
It is assumed that they play an important role to control the access of osteoclast 
to native bone matrix. Thus, the lining cells can secret collagenase, which 
removes the matrix before osteoclasts can attach to bone. Further, it has been 
shown that under certain circumstances, e.g. mechanical force or stimulation by 
PTH, bone lining cells can reconvert to osteoblasts. Another important function 
of the lining cells is to create specialized compartments on the surface of 
trabecular bone in which the remodeling process takes place. (Dempster 2006).  
(Manolagas 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: A light microscopic (LM) image of undecalcified trabecular bone section 
(3!m thick) stained by Giemsa staining: LC= lining cells (dark blue); dark pink= 
mineralized bone, light pink= osteoid (region adjacent to lining cells) (source: LBIO). 
 
 
 
 29 
2.3. Bone Development, Growth and Maintenance 
 
During embryonic development and growth of the skeleton 206 separate bones 
are formed. Between three principles in bone formation and its combination can 
be distinguished: a) intramembranous, b) endochondral ossification (Maes et al. 
2007) and c) perichondral ossification. 
 
 
2.3.1 Intramembranous Ossification 
 
The bone is formed after a template of a dens membranous tissue of collagen 
bundels. A mesenchymal group of cells within a highly vascularized area of the 
embryonic tissue proliferates and differentiates directly into preosteoblasts and 
then into osteoblasts. These cells synthesize a characteristic bone matrix:  
- it consists of collagen fibers which are not preferentially oriented, appear as 
irregular bundles and form a dense membranous tissue 
-  it includes a large number of osteocytes which are also larger in size 
- its mineralization is delayed and does not proceed in an orderly fashion but in 
   irregularly distributed patches, however reaches finally a higher level of 
   mineral content than lamellar bone. 
- these motifs of woven bone serves as scaffold on which primary lamellar 
   bone is layed down. The primary bone is in the following replaced by 
   secondary/remodeled lamellar bone (Baron 1999; Mackie et al. 2008).  
Bones formed in this manner are the flat bones of the skull (calvaria bones and 
mandibles) and parts of the clavicles. 
 
 
2.3.2. Endochondral Ossification 
 
In contrast to intramembranous ossification, in endocortical ossification bone is 
formed by a cartilage template, like in short and long bones. Endochondral 
ossification starts that in centre of a cartilage template, e.g. vertebra. The 
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chondrocytes become hypertrophic and the cartilage matrix starts to mineralize. 
Simultaneously blood vessels are invading to the hypertrophic zone and 
osteoblasts and osteoclasts are accumulating. The osteoblasts lay down the 
first bone matrix on the mineralized cartilage motifs, while the osteoclasts are 
resorbing the mineralized matrix (bone and cartilage). Both processes together 
lead finally to a young trabecular bone, which further gets continuously 
(re)modeled.   
 
 
2.3.3. Perichondral Ossification 
 
This type of ossification is a kind of combination of intramembranous and 
endochrondal ossification and occurs in all long bones. The long bone is also 
formed after a cartilage template. The first ossification center is at the midshaft 
region of the diaphysis. From the surrounding perichondrium tissue osteoblasts 
start first to develop and to form a bone collar around the cartilage template by 
intramembranous ossification. Additionally, blood vessels and osteoclasts 
accumulate within the perichondrium, and subsequently invade to the 
underlying hypertrophic mineralizing cartilage region. Subsequently, the 
endochondral ossification process starts involving osteoblasts and osteoclasts. 
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Figure 14: Early events during peri- and endochondral ossification of long bone: 
1. Osteoblasts develop from the surrounding perichondrium at midshaft region and 
form a membranous bone collar. 2. Within the cartilageous scaffold chondrocytes 
differentiate into hypertrophic chondrocytes (HC) and the cartilage gets mineralized 
(start of primary ossification center). 3. Blood vessels and osteoclasts accumulate 
within the perichondrium and invade and erode the hypertrophic cartilage 
(endochondral ossification); formation of the primary ossification center (POC).(After: 
Maes 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15:A Schematic of the zones of bone growth at the epiphyseal growth plate (left) 
and a backscattered electron image of the same region. C = uncalcified growth 
cartilage, mdC = mineralized cartilage and B&mdC = Bone and mineralized cartilage 
(bone matrix dark gray, cartilage matrix light gray).(Source: LBIO). 
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2.3.4. Growth of Bone 
 
In general, the growth in size and/or length of bone is accomplished by 
cartilagous growth plates. At the periphery of this cartilage (the perichondrium), 
the mesenchymal cells continue to proliferate and differentiate. This process is 
called appositional growth. Deeper in this tissue the cells differentiate into 
prechondroblasts and then into chondroblasts. These cells secrete the 
cartilaginous matrix. Like the osteoblasts, the chondroblasts become embedded 
in their own matrix, where they lie in the chondrocyte lacunae as chondrocytes. 
In contrast to the osteocytes, the chondrocytes continue to proliferate for some 
time and form regular columns called isogenous groups. Subsequently, the 
chondrocytes enlarge progressively, become hypertrophic and apoptotic (Baron 
1999). This zone of cartilaginous matrix starts to mineralize and gets ossified by 
endochondral ossification, which increases the dimension of bone. 
 
 
2.3.5. Modeling / Remodeling 
 
Bones are designed to optimally resist impacts by their functional activities. 
Thus, the tissue must be constantly reshaped and remodeled to adapt for 
changes in stress environment and to maintain its mechanical competence.  
 
Modeling refers to new bone apposition of bone matrix on sites it has not been 
before, whereas remodeling refers to its replacement on surfaces previously 
containing bone (Boskey 2006). This means, that all growth of bone until 
adolescence and all adaptation to mechanical stress modeling processes are 
essentially involved too. In this situation the osteoblasts are working at forming 
sites apart not in close neighborhood with the osteoclasts as in remodeling. E.g. 
the process of growth in the diameter of the shaft is the result of a deposition of 
new bone beneath the periosteum that will continue throughout life. In this case, 
resorption does not immediately precede formation, but takes place in the 
endosteal region. 
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Bone remodeling occurs by removal of old bone (resorption) by osteoclasts, 
followed by new bone formation by osteoblasts. A key molecular regulator 
system of bone resorption are RANK, RANK ligand (RANKL) and 
osteoprotegerin (OPG) (Blair et al. 2007). The remodeling process allows bone 
to fulfill its structural and metabolic functions. Thus, bone is a dynamic tissue 
that accomplishes by constant resorption and formation 
 
   * the maintenance of bone tissue  
* the repair of damaged tissue  
* the homeostasis of the phosphocalcic metabolism. 
 
Through this balanced phenomenon of remodeling, about 5% of cortical bone 
and 20% of trabecular bone, approximately 5 to 10% of total bone, are renewed 
per year. Cortical bone makes up 80% of the total volume, but the metabolic 
rate is 10 times lower, because the surface area to volume ratio is much 
smaller. Bone remodeling or bone turnover occurs throughout a person’s life. 
The remodeling of each packet takes place in temporally constant cycles of 3-4 
months, but differs for cortical and trabecular bone. Only up to the third decade 
the balance is positive, in the third decade of life, when bone mass has reached 
its maximum, the level is maintained with small variations until the age of 50. 
From this time on resorption predominates and the bone mass begins to 
decrease. 
At the microscopic level, bone remodeling takes place in small areas of the intra 
-cortical and the trabecular surface, known as basic multicellular units (BMU). In 
cortical bone, the BMU moves through the bone matrix, excavating and 
replacing a tunnel. In trabecular bone, the BMU moves across the trabecular 
surface, excavating and replacing a trench (Manolagas 2000). Resorption 
always precedes formation and in the young skeleton the amount of resorbed 
bone is similar to the newly formed bone. The average lifespan of each 
remodeled unit in humans is 6-9 months, much longer than the lifespan of its 
executive cells [lifespan of osteoblasts (active) " 3 months, lifespan of 
osteoclasts " 2 weeks] of which the greater part is taken up by bone formation. 
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In a recurring sequence of 10 years the skeleton is completely renewed (Parfitt 
1994; Fernandez-Tresguerres-Hernandez-Gil et al. 2006b). 
 
 
The Remodeling Cycle: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Bone remodeling cycle characterized by six phases 
 
 
 
Bone remodeling can be divided into six different phases (Fig. 16). 
 
1. Resting phase: 
During this phase, no resorption or formation of bone takes place the lining cells 
are covering the bone surface. 
 
2. Activation phase:  
The process of activation involves retraction of lining cells and digestion of the 
endosteal membrane by collagenase action. The mineralized surface attracts 
the circulating osteoclasts coming from the nearby vessels. The osteoclast 
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formation, activation and activity are regulated by local cytokines (RANKL, 
Interleukins (IL1 und IL6), colony stimulating factors (CSF’s) and systemic 
hormones (PTH, vitamin D, calcitonin) (Blair et al. 2007). 
 
3. Resorption phase:  
The osteoclasts begin to dissolve the mineral matrix and decompose the 
osteoid matrix. This process is completed by the macrophage and permits the 
release of the growth factors, transforming growth factor beta (TGF-#), platelet 
derived growth factor (PDGF) and insulin-like growth factor I and II (IGF-I, IGF-
II). 
 
4. Reversal phase:  
After osteoclasts withdraw and or apoptosis the reversal phase, the first step in 
the repair process, starts. Not cleaned out collagen in the resorption lacuna is 
removed by specific mononuclear cells, which deposit a thin layer of 
proteoglycans to form the cement line. After this surface preparation, the 
formation of new bone is starting.  
 
5. Formation phase:  
The osteoblasts lay down unmineralized matrix (type 1 collagen) in a well 
organized way (lamellar fibril arrangement) into the resorption lacuna. This layer 
of new bone is called osteoid.  
 
6. Mineralization phase:  
After a certain maturation time the mineralization starts. The process is biphasic 
with an initial fast (primary mineralization) followed by a slow (secondary 
mineralization) phase. As more and more extracellular matrix is produced, some 
of the osteoblasts are implemented in the mineralized bone and become 
osteocytes. When the resorption space is filled osteoblasts become lining cells 
or die through apoptosis.  
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Figure17: Skeletal remodeling in health and disease. The skeletal maintenance is 
accomplished by multiple factors including hormonal, nutritional, cellular (osteocyte, 
osteoblast = Ob, osteoclast = Oc), hematopoetic system, brain, kidney, liver and 
mechanical stimulation (source: LBIO).  
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2.4. Bone Quality 
 
The strength of bone is not determined only by its mass, but by its the structural 
and material properties. Thus, bone quality can be understood as an umbrella 
term that describes the set of characteristics for all hierarchical levels of bone 
that influences bone strength at a constant bone mass. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16: Bone quality framework - contribution to bone strength (Schriftgrößen?) 
 
 
 
 
 
 
 
Figure 18: Bone quality framework – contribution to bone strength 
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3. MEASUREMENTS OF BONE MINERALIZATION 
PROFILES (BM-PROFILE) 
 
 
3.1. Subjects and Diseases 
 
Controls for Young individuals:  
As controls served biopsies from individuals (n=13) (age, 2.1 to 20.8 yrs) 
without any sign of metabolic bone diseases. These biopsies were already used 
in previous studies (Roschger et al. 2008a; Fratzl-Zelman et al. 2009). 
 
Controls for Adult individuals: 
Transiliac biopsies from healthy premenopausal women (n=8) (premenopausal 
woman) used already in previous studies were employed for adult controls 
(Roschger et al. 2003) 
 
Osteogenesis imperfecta (OI): 
OI type I is a genetic disorder associated with increased bone fragility. In the 
majority of patients, mutations affecting collagen type I can be attributed to the 
typical OI phenotype (Roschger et al. 2008a). One of the exceptions of OI 
where the altered collagen synthesis is not caused by a genetic mutation of 
collagen type I is OI type VII. This form of OI is caused by the posttranslational 
modification of the collagen in the extra cellular space due to CRTAP (cartilage-
associated protein) mutations. CRTAP is a cofactor important for this process 
(Morello et al. 2006) 
 
Biopsies from patients (n=5) (age 3.3 to 13 yrs) with OI type I (Roschger et al. 
2008a) and OI type VII (n=4) (age 2.3 to 12,2 yrs) (Ward et al. 2002) were 
studied. 
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Hypoparathyroidism:  
Hypoparathyroidism (hypoPT) is a clinical disorder that usually appears when 
the parathyroid hormone (PTH) secretion by the parathyroid gland is decreased 
or insufficient to maintain extracellular fluid calcium in the normal range 
(Gotzman and Cole 2006).  
PTH is an important regulator of the calcium- and phosphorus concentration in 
extracellular fluid. It is secreted from the parathyroid gland and the target cells 
are in bone, kidney and the small intestine (Benninghoff 1993). The three main 
effects of PTH are: 1. The mobilization of calcium from bone by stimulating the 
osteoclasts to reabsorb bone mineral and liberating calcium into blood. 2. The 
PTH stimulation of the process of calcium absorption from the small intestine, 
resulting in elevated blood levels of calcium. 3. The production of the active 
form of vitamin D in the kidney is stimulated through this process. The synthesis 
of a calcium-binding protein in intestinal epithelial cells, caused by vitamin D, for 
effective absorption of calcium into blood. The parathyroid hormone reduces the 
excretion of calcium in urine thereby conserving calcium in blood. 
 
There are four reasons of hypoparathyroidism:  
 
1) failure of parathyroid gland development 
2) destruction of the parathyroid glands (removal by surgery) 
3) reduced PTH production by altered parathyroid gland function 
4) impaired PTH action. 
 
Ad 1) Congenital agenesis of the parathyroid glands can produce 
hypoparathyroidism in the newborn child. Many cases with the DiGeorge 
phenotype are the result of de novo deletions, autosomal dominant inheritance 
is not uncommon and such families require detailed genetic examination Ad 2) 
In adults is surgical excision of the parathyroid glands the most common cause 
of hypoparathyroidism as a result of total thyroidectomy for thyroid cancer or 
repeated operations for primary hyperparathyroidism. Ad 3) The altered 
regulation of parathyroid gland function may be primary or secondary. Primary 
alterations of parathyroid gland secretion are most commonly caused by 
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activating mutations of the CaSR gene. These mutation decrease the set point 
for calcium, increase the sensitivity to extracellular fluid calcium concentration 
cause a functional hypoparathyroid state with hypocalcemia and hypercalciuria. 
The consequence of the activated parathyroid gland CaSR is chronic 
suppression of PTH secretion and the activated CaSR in kidney induces 
hypercalciuria that exacerbates the hypocalcemia (Gotzman and Cole 2006).  
 
Young patients with CaSR (n=3) (age 13 to 22 yrs) (Theman et al. 2009), 
DiGeorge (n=2) (age 14 yrs) and idiopathic hypoPT (n=1) as well as adult 
patients with DiGeorge (n=1) and hypoPT by surgical removal PT gland (n=1) 
were investigated. 
 
 
Osteoporosis - fragility and susceptibility to fractures: 
Osteoporosis has been defined by WHO in 1993 as “a systemic skeletal 
disease characterized by low bone mass and microarchitectural deterioration of 
bone tissue with a consequent increase in bone fragility and susceptibility to 
fracture” (The American Journal of Medicine 1991;90:107-110). 
 
WHO working group (1994) defined BMD threshold for diagnosis of post 
menopausal osteoporosis (PMO) by DXA: Numbers of standard deviations 
below the young-adult mean value of BMD (ultimately called a “T-Score“) are 
used for classification:  T-Score  <= -2.5  osteoporosis 
T-Score  -1 to -2.5 osteopenia 
However, a better definition of osteoporosis might be: Osteoporosis is the 
consequence of a stochastic process, that is, multiple genetic, physical, 
hormonal and nutritional factors acting alone or in concert to diminish skeletal 
integrity R. Marcus (1996). 
The primary osteoporosis, which is heterogeneous in types, includes 
postmenopausal, senile osteoporosis and idiopathic osteoporosis. The term 
idiopathic osteoporosis is used for younger men and premenopausal woman 
with osteoporotic fragility fractures without identifiable secondary causes (Raisz 
2008).  
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Transiliac bone biopsies from patients with postmenopausal osteoporotic 
women receiving Ca and Vit D (n=9) used already in previous studies were 
investigated (Meunier et al. 2004; Reginster et al. 2005).  
 
 
Osteopetrosis: 
Decreased bone turnover can also lead to skeletal abnormalities. There are 
several syndromes of osteopetrosis, in which bone resorption is defective 
because of impaired formation of osteoclasts or loss of osteoclast function 
(Pycnodysostosis) (Fratzl-Zelman et al. 2004). In this disorder, bone modeling 
as well as remodeling are impaired, and the architecture of the skeleton can be 
quite abnormal (increased bone volume and cortical thickness).  
 
A transiliac bone biopsies from one patient with osteopetrosis was studied.  
 
 
Osteonecrosis: 
The disease osteonecrosis, also known as avascular necrosis, aseptic necrosis 
or ischemic necrosis of bone, is the necrosis of a bone segment, and is a result 
of temporary or permanent interruption of blood supply to the bone tissue. 
  
Osteonecrotic femoral head bone tissue from patients (n=4) was investigated. 
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3.2. Sample Preparation 
 
All bone samples were fixed in 70% ethanol, dehydrated in a series of ethanol, 
and embedded in polymethylmethacrylate. Sample blocks were trimmed using a 
low speed diamond saw (Isomet-R, Buehler Ltd. Lake Buff, IL, USA). Sectioned 
bone surfaces were sequentially grinded with sand paper with increasing grid 
number followed by polishing with diamond grains (size down to 0.25 microns) 
on hard polishing clothes by a PM5 Logitech instrument (Glasgow, Scotland). 
Finally the sample surface was carbon coated by vacuum evaporation with Agar 
SEM Carbon Coater, Agar Scientific Limited (Standsted, Essex, UK). 
 
3.3. Quantitative Backscattered Electron Imaging (qBEI) 
 
The validated technique of quantitative backscattered electron imaging (qBEI) 
allows the assessment of the degree of mineralization of polymethylmetacrylate 
(PMMA) embedded bone biopsies (Roschger et al. 1995; Roschger et al. 1998; 
Roschger 2003; Roschger et al. 2008a; Roschger et al. 2008b). The technique 
facilitates the description of the distribution and mean of weight percent calcium 
for cancellous and trabecular bone. Quantitative backscattered electron imaging 
is based on the visualization and quantification of bone matrix with its different 
degrees of mineralization, caused by bone packages of varying mineral content.  
 
The sectioned plan-polished bone surface is scanned by an electron beam in a 
scanning electron microscope (SEM). Only the electrons backscattered with 
high energy from the sample surface are detected and used for the image 
generation. The intensity of the backscattered electrons (BE) is directly 
proportional to the atomic number of the sample material (Z-number contrast). 
Thus, in a mineralized tissue with calcium of an atomic number Z=20 and an 
organic matrix of Z~6, the calcium content is dominating the BE-signal and the 
grey levels in the BE-image have the meaning of Ca-content, bright reflects high 
and dark low Ca-content. In order to calibrate the BE-grey levels carbon (C, 
Z=6) and aluminum (Al, Z=13) were used as standards to calibrate the 
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microscope (Roschger et al. 1998). The grey levels of C and Al are adjusted 
always to 25 and 225, respectively, thus in all qBEI measurements the BE-grey 
levels are guaranteed to have the same physical meaning (a specific Z 
number). 
 
For the qBEI imaging a scanning electron microscope (DSM 962, Zeiss, 
Oberkochen, Germany) equipped with a four quadrant semiconductor 
backscattered electron detector is used. The SEM is operated at 20 keV 
electron beam with a probe current of 110 pA. The working distance is 
maintained at 15 mm. The magnification is adjusted to a 50x nominal resulting 
with a resolution of 4 microns/pixel, so fare the BMDD of the bone sample is 
measured. However, for the BM-profiles, the ROI is imaged with a nominal 
magnification of 400x corresponding to 0.5 microns/pixel. The areas are 
scanned with a speed of 100 sec/frame, generated by a single frame.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19: Quantitative backscattered electron imaging method to assess the bone 
mineralization density distribution (BMDD): 1. Acquirement of calibrated backscattered 
electron images in SEM. 2. Derivation of grey-level histograms  (BMDD) describing the 
frequency of appearance of a certain mineral concentration throughout the bone area, 
which is the product of remodeling and kinetics of matrix mineralization. 3. Calculation 
of five BMDD parameters for characterization of the BMDD curve: CaMEAN, CaPEAK, 
CaWIDTH, CaLOW and CaHIGH.(Source: LBIO). 
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Using methods of digital image processing and analysis (NIH Image 1.63, 
National Institute of Health, USA) grey-level histograms (frequency distributions) 
are derived from the BE-images and transferred to bone mineralization density 
distribution (BMDD). To be able to quantify differences in the BMDD histograms 
and to make statistical analyses, five parameters have been established: 
CaMEAN, CaPEAK, CaWIDTH, CaLOW, CaHIGH (Roschger et al. 1998; Roschger et al. 
2008b).  
1. CaMEAN, is the weighted average Ca concentration of the mineralized bone 
area, obtained from the integrated area under the BMDD curve.  
2. CaPEAK, is the most frequently measured wt% Ca of bone area, indicated by 
the peak position of the BMDD histogram.  
3. CaWIDTH, measures the heterogeneity of mineralization, caused by the co-
existence of bone packets with different degrees of mineralization. It is obtained 
by evaluating the width at half-maximum of the BMDD histogram.  
4. CaLOW, is the amount (%) of bone area with a lower degree of mineralization 
than the value at the 5th percentile of the reference BMDD, which was found to 
be lower than 17,68wt% Ca. CaLOW represents the amount of bone in the range 
of calcium concentration, which is achieved during primary mineralization (Misof 
et al. 2003). 
5. CaHIGH indicates the % bone area exhibiting a Ca concentration above the 
95th percentile value of the reference BMDD, which was found to be higher than 
25.30wt% Ca. It indicates fully mineralized mainly interstitial bone. A remarkable 
small biological variation in BMDD was found in healthy adult human trabecular 
bone (Roschger et al. 2008b). BMDD was independent of the skeletal sites 
studied, ie.: iliac crest, vertebrae, patella, femoral head and femoral neck, as 
well as independent of age (25 to 90 years) and ethnic origin (caucasian and 
afro-american) (Roschger et al. 2003). Thus a single reference BMDD for adults 
could be introduced (Fig. 20) 
 
The measurements of BM-profiles are performed along lines with 4 pixels in 
widths perpendicular to the mineralizing front across the BSU with a step size of 
0.5 !m. The pixel grey-level or the corresponding Ca-content values (Fig. 23) 
are plotted vs the depth into the forming BSU. 
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Figure 20: Reference data for bone mineralization density distributions (BMDD) of a 
trabecular bone for a young and an adult reference collective (see appendix). (After: 
Roschger et al. 2003; Roschger et al. 2008b; Fratzl-Zelman et al. 2009) 
 
 
3.4. Region of Interest (ROI) - Forming BSU 
 
During the remodeling cycle (phase 5, Fig. 16) new bone matrix (osteoid) is 
continuously formed by osteoblasts After a lag time the osteoid becomes 
mineralized following a certain time course. In a forming BSU at least three 
fronts are moving with a synchronized speed in the direction to the bone 
marrow space: 1) The coordinated action seam of osteoblasts 2) the surface of 
new synthesized collagen, 3) the mineralization front (Fig. 21). For this reason a 
histological section of such a BSU includes all phases of bone formation in a 
spatial sequence (Fig. 22). In consequence, the increasing Ca-content of the 
collagen matrix in such forming BSU reveals information about the phases and 
kinetics of the mineralization process.  
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Figure 21: Sketch of a forming basic structural unit: The osteoblasts secrete 
collagenous matrix material (osteoid), which mineralizes after a certain mineralization 
lag time (Mlt). Throughout the mineralization front the mineralization starts with 
formation of nucleation centers. The mineralization front is moving in the direction of 
the osteoid with a certain speed, the mineral apposition rate (MAR). The new bone 
matrix is mineralized rapidly up to 70% of final mineralization. The whole forming period 
(FP) of a BSU is about 180 days.  
 
 
Osteoid: In this zone new bone matrix not yet mineralized is found. The seam 
of osteoblasts on the surface of the forming BSU synthesis mainly procollagen, 
which is then secreted in the extra celluar space. After some extra cellular 
modification and self-assembling processes of the collagen molecules type I 
collagen fibrils are arranged in a lamellar way. Additionally, other non-
collagenous proteins are incorporated in the extracellular matrix like, such as 
osteonectin, osteopontin, osteocalcin, bone sialoprotein, proteoglycans, 
phosphoproteins and proteolipids. The osteoblasts express a characteristic 
enzyme, the alkaline phosphatase (ALP), which plays an important role in the 
subsequent mineralization of the matrix. The front of osteoid is moving this way 
about 0.6 to 1 !m per day. Characteristically, the new osteoid matrix is not 
mineralized immediately but after a certain lag time of about 13 days. This 
means, that an osteoid seam of about 7 !m in thickness is generated between 
the osteoblasts and the mineralization front. It can be speculated, that this 
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spatial distance to the osteoblast seam is needed, because of the toxic 
extracellular concentration of calcium present in the mineralization zone. 
Moreover, a certain time for the maturation in the collagenous matrix, like cross 
linking and fibril modification, seems to be a prerequisite of matrix 
mineralization. 
 
Mineralization Front: In this zone the mineral content is rapidly increasing from 
zero to a first plateau level. The underlying mechanism of initiation and progress 
in mineralization of osteoid is not yet fully understood. The mineralization of the 
collagen matrix is a highly controlled process, affected by the cross-link profile 
and regulated by non-collagenous proteins (NCP), which are found in the 
organic bone matrix. It is widely accepted, that the mineralization starts in the 
gap zones (Landis et al. 1996) by seeding/formation of nucleation centers 
followed by an rapid growth of the mineral crystals. Most likely the rapid initial 
growth of the crystals occur first predominantly in two dimensions (thin plates) 
and the bone matrix reaches the first plateau of mineralization (30% below final 
value) within few days (primary mineralization). Thereby the crystals are 
extending in the overlap zones of the collagen and form a 
staggered/overlapping parallel arrangement of the mineral plates (Fig. 4) of 2-4 
nm thick plate like aggregates within the fibril (Gao et al. 2003). Thereby the 
mineralization front is moving towards the osteoid or osteoblast seam with 
about 0.6 to 1.0 !m per day. The so called mineral apposition rate (MAR) is 
measured by fluorescence double labeling of the mineralization front. For this 
purpose the patient receives  twice tetracycline (with about 12 days between 
first and second dose) shortly before biopsy. Two fluorescence bands in the 
biopsy section mark then the progress of the mineralization front within 12 days. 
 
Bone Matrix of Young BSU: In the zone behind the mineralization front the 
bone matrix increases its mineral content by a second phase of mineralization. 
In this phase mainly the thickness of the mineral plates is increasing (secondary 
mineralization) (Roschger et al. 2001; Fratzl et al. 2004a), which lasts in a time 
scale of months and years. In this phase of mineralization the mineralization of 
the bone matrix may extend also to the extra fibrilar space. Moreover, the 
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organic phase (cross-links) and the mineral crystals (calcium ion substitution - 
carbonation) are undergoing a chemical maturation process. 
 
Cement Line/Surface: During the bone remodeling cycle, after bone resorption 
of osteoclasts has stopped, a thin highly mineralized layer of proteoglycans and 
non-collagenous proteins (NCP) is laid down on the bone surface where 
resorption took place (reversal phase, see. Fig. 6 and 16). It is assumed that 
this layer provides a contact surface for the new bone matrix and may act as a 
glue. In general, the lamellar orientation is changing at the cement line between 
the old and the new bone packet.  
 
 
3.5. Analysis of BM-Profiles 
 
Identification of a forming BSU: The forming BSUs had to be identified on the 
block section of trabecular or cortical bone only by criteria which the qBEI 
method is providing. Though the qBEI method is in principle only showing a 
material contrast (Ca-content) and not any histological details like osteoblast, 
osteoid or fluorescence double labeling bands (Fig. 26), clear criteria had to be 
found for the routinely identification of a forming BSU in the BE-image 
(demonstrated in Fig. 23). The criteria, which were sufficient for the selection for 
BM-profiles were: 
 
 1) The BSU had to be on the bone surface and was carrying a well 
 defined wide dark surface seam. 
 2) Additionally the BSU showed evidence of an osteoid seam, which  
 could be distinguished from embedding medium just yet by its   
 material contrast in the BE-image (Fig. 20). 
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Figure 22: Identification of forming BSU: (A) Light microscopic (LM) image of a 
histological section shows a forming BSU stained by Giemsa staining: Pink= old 
mineralized bone packet; light blue= Osteoid; dark blue cellular motifs= osteoblasts. 
Black arrows indicate the cement line of the bone packet. (B) qBEI image of identical 
area of (A) showing only the mineralized part of the bone tissue. (A+B) Combination of 
the LM and the qBEI image: the forming BSU is characterized by a seam of osteoblasts 
(white arrows) followed by osteoid and an adjacent region of low mineralized bone 
(dark grey), the mineralization front. Black arrows indicate the cement line between 
forming and preexisting bone packet, source LBIO. 
 
 
Selecting Lines for BM-Profile analysis: The BSUs classified as forming 
tissue regions (ROI) were imaged by qBEI method using a pixel resolution of 
0.5 !m per pixel. Then using digital imaging processing and analysis methods a 
tool for generating profiles were applied (NIH Image 1.63, National Institute of 
Health, USA): a) Straight line areas 4 pixel wide were drawn in the digital image 
by "straight line" tool starting in the osteoid or embedding medium, 
perpendicular to the mineralizing front and ending in the adjacent old BSU 
(Fig.23).  
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b) Then the analyze mode "plot profile" was activated, which was providing the 
pairs of plot data. The x-axis was indicating the distances/positions along the 
line in steps of 0.5 !m (Fig.24). The y-axis was showing the corresponding Ca-
content values to each single line position. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23: Measurements of bone mineralization profiles (BM-profiles): 1. qBEI images 
with a pixel resolution of 0.5!m x 0.5 !m were performed from forming BSU: Forming 
BSU is  identified by its dark rim of low mineralized bone matrix. By use of density slice 
(red colour) the presence of osteoid is visualized. 2. Lines (4 pixels wide) were drawn 
perpendicular to the mineralization front for the determination of BM-profiles (source: 
LBIO).  
 
The Ca content was calculated from the average grey level resulting from the 
four "line pixels" at each position. The reason to use a line width of four pixels 
instead of only one was to reduce the effect of the signal noise due to counting 
statistics by signal averaging. Thus, the line profile became less noisy. 
 
Determination of the Transition Point CaTURN: The obtained plots of calcium 
(Ca) content and line position were analyzed by linear curve fitting in two 
regions of the data (Fig. 24): 
1) The first line started at the beginning of the mineralization front (steep rising 
Ca content) and ended before the Ca values reached a plateau. 
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2) The second line started at the beginning of the plateau (flat rising Ca values) 
and ended before the profile line reached the adjacent old BSU. In cases of 
short plateau regions e. g. in very young forming BSU or disturbances in the 
bone matrix (osteocyte lacunae, non uniform fibril arrangement), the second line 
fit was replaced by a horizontal line through the mean of the corresponding data 
points.  
3) The intersection of the two linear fits defined the Ca value (value at the y-
axis) where the fast mineralization process was changing to the slow 
mineralization process designated by us as "CaTURN" (Roschger et al. 2008a; 
Roschger et al. 2008b). Fig. 24 is demonstrating an example for the variation in 
CaTURN data as obtained within an individual (male, 8.8 yrs) by multiple BM-
profile measurements (n=47). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24: BM-profile as measured by qBEI - evaluation of CaTURN: 
X-axis = position of measurement (distance to the mineralization front) with a 
step size 0.5 !m. Y-axis = corresponding calcium content in weight %. 1. 
Characterization of BM-profile by two linear fits: initial steep slope (P) (primary 
mineralization) followed by flat slope (S) (secondary mineralization). 2. 
Determination of the transition point CaTURN by the intersection of both linear 
line fits characterizing the transition from a fast to a slow mineralization process. 
 
 
 52 
 
 
 
 
 
 
 
 
 
 
 
Figure 25: Example of CaTURN measurement: Scatter plot of CaTURN data from a 8.8 
years old healthy boy (control) generated by evaluation of 47 line profiles of five 
different BSUs in a transiliac biopsy. Median [25% ; 75%] = 20,1 [19,8 ; 20,4]. 
 
 
Introduction of a Time Scale to the BM-Profile: 
In principle the BM-profile analysis in the forming BSU gives only spatial 
information of mineral content of matrix volume elements along a line 
perpendicular the mineralization front, but does not directly provide any 
information about the temporal development of the mineral content of a single 
volume element of bone matrix. However, the forming BSU with its progressing 
mineralization front displays the time course of mineralization by different bone 
matrix volume elements as sequence of increasing distance to the 
mineralization front (Fig. 24). 
 
Fluorescence labeling technique: 
Bone biopsy samples are usually fluorescence labeled in a specific manner: 
intake of tetracycline e.g. first label - tetracycline (green) thrice-daily 
dosage/three days, wait of 12 days; second label - declomycin (yellow) twice-
daily/three days, wait for 5 days, then performance of biopsy. Since the 
tetracycline binds selectively to the newly formed bone matrix (matrix at the 
mineralization front) two fluorescent bands are generated which can be 
identified by fluorescence microscopy. The distance between the fluorescent 
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bands is a measure how much the mineralizing front was moved forward within 
12 days. This progress of the mineralization front per day averaged over the 
entire biopsy sample is called the mineral apposition rate (MAR) one of the 
primary parameters of dynamic bone formation in histomorphometry. In 
consequence, for a first estimate, the distances to the mineralization front can 
be transferred into a sequence of time points of mineralization, assuming that 
the mineralization front moves with a constant speed within the BSU.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26: Time scale of a BM-profile: (A) Fluorescence double labeling of bone - 
Imaging by confocal laser scanning microscope (CLSM) visualizes two fluorescent 
bands marking the position of the moving mineralizing front at day 20 and day 6 before 
biopsy (see also Figure 27) (B) qBEI image of the identical bone area of (A) bone 
showing local calcium content of bone matrix. (A+B) Overlay of qBEI image with 
corresponding fluorescence image allows to relate the calcium content with time period 
of mineralization (tissue age) (Figure 27), (after: Misof et al. 2003) 
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Figure 27: Profile of mineralization density at a forming BSU. The mineralization profile 
is combined with fluorescence double labelling. The first tetracycline labelling was done 
at day 20 before biopsy, the second labelling at day 6. Day zero is the day when the 
biopsy is taken. It can be seen that the mineralization density reaches here its plateau 
within six days.  
 
 
A more accurate possibility for assigning the Ca-content to specific time points 
is a combination of CLSM and qBEI on identical BSUs. The CLSM fluorescence 
image is overlaid with the qBEI image of the identical BSU region and the 
positions of the fluorescence labels are transferred to BM-profiles directly as 
time markers (Fig. 27). 
Consequently, in biopsy samples with fluorescence labeling the BM-profile 
measurements allow not only the determination of the level of mineral content 
when primary mineralization turns to secondary mineralization, but also how 
fast this point is reached defining the speed of primary mineralization.  
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Statistical analysis: Statistical analysis was performed using Prism 4, 
GraphPad Prism Version 4.0, GraphPad Software Inc., San Diego CA 2003. 
The median of the BM-profiles data obtained per patient was used to represent 
the CaTURN of the patient. The significance of differences between control and 
groups of patients were analyzed by Mann-Whitney tests (non-parametric 
analysis) (Table 1). Correlations of CaTURN of young individuals and adults with 
corresponding parameters of BMDD were performed using Spearman 
correlations (non-parametric analysis) (Table 2). All differences and correlations 
were considered significant at p < 0.05. 
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4. RESULTS 
 
In this study bone biopsy samples of 75 individuals were measured for the 
transition point CaTURN between primary and secondary mineralization. The 
median of CaTURN was determined from 5 to 86 BM-profiles per individual 
depending on the number and size of forming BSUs found within the bone 
section. Further, the CaTURN values were correlated with the corresponding 
BMDD-parameters obtained from in the same bone sections. 
 
4.1. CaTURN of Young Individuals (age range 2.1 to 20.8 
years) 
 
Controls: A subgroup of the young reference group, which were used to 
establish normative data for BMDD of young individuals were analyzed (see 
appendix (Fratzl-Zelman et al. 2009)). A median of 19.75 weight% Ca for 
CaTURN was found for the young controls. The CaTURN value and the 
corresponding BMDD parameters are listed in Table 1. Correlation analysis of 
age and CaTURN did not show any correlation (r=0.26, p=0.39) (Fig. 32). 
Estimate of time point when CaTURN is reached (TTURN) is 16 days based on an 
average MAR of young individuals (0.9!m/day).  
 
Children with OI type I & OI type VII: In these groups five patients with  
OI type I  and four patients with OI type VII were measured for CaTURN. 
Statistical comparison revealed a significant increased of CaTURN, for OI-I 
+9.0%, p<0.001 and for OI-VII +5.2%, p<0.01, respectively, compared to 
controls (Table 1, Fig. 28). 
 
Young Individuals with CaSR: In these group two patients with age of 13, 14 
years and one with 19 yrs were measured for CaTURN. Statistical comparison 
revealed a significant decrease in CaTURN, (-16%, p<0.001), compared to 
controls (Table 1, Fig. 28). 
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Correlation CaTURN vs BMDD Parameters for all Young Individuals: Fig. 28 
displays examples of single BM-profiles from three individuals (one control, two 
with bone diseases) together with the corresponding bone mineralization 
density  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28: Example of individual BM-profiles from children with genetic disorders: 
Control = healthy individual, OI type I= patients with osteogenesis imperfecta type I, 
CaSR = patient with an activating mutation of the calcium sensing receptor. The 
deviations from control CaTURN indicate disturbances of the primary mineralization 
process in these patients. 
 
distribution (BMDD) curves to demonstrate the relationship between CaTURN and 
BMDD-parameters. When CaTURN values were correlated with the 
corresponding BMDD parameters describing the average (CaMEAN) and the 
most frequent (CaPEAK) Ca-content of the entire cancellous bone compartment, 
a strong positive linear correlation was obtained. For BMDD parameters 
CaWIDTH the correlation was negative, while for CaLOW no significant correlation 
was found (Table 2).  
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Figure 29: Example of bone mineralization density distributions (BMDD) of a patient 
with an activating mutation of the calcium-sensing receptor (CaSR) (age, 13 to 22 yrs 
and with osteogenesis imperfecta (OI type I) (age, 3 to 14 yrs) compared that of a 
young control reference group (Fratzl-Zelman et al. 2009). The CaSR patient has the 
BMDD shifted towards lower mineralization density and the heterogeneity is increased. 
The OI type I patient has the BMDD shifted towards higher mineralization density and 
the heterogeneity is reduced 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 30: Correlation between CaTURN and CaPEAK values of CaSR, OI patients and 
young controls. 
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Figure 31: Comparison of median CaTURN values of healthy young controls (YOUNG 
CONTROL) and osteogenesis imperfecta type I (OI-I), osteogenesis imperfecta type 
VII (OI-VII) and activating mutation of calcium sensing receptor (CaSR). *p<0.5, 
**p<0.01 sigificance level of differences with respect to young control.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 32: Correlation analysis between age and CaTURN of young healthy individuals 
revealed no age dependency of CaTURN.  
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Figure 33: Correlation analysis between CaTURN and the five bone mineral density 
distribution (BMDD) parameters: CaMEAN, CaPEAK, CaHIGH are positively, while CaWIDTH  
and CaLOW are negatively correlated with CaTURN. 
 
 
 
 
 
4.2. CaTURN of Adult Individuals (age range 21 to 58 
years) 
 
Controls: As controls served biopsies from 8 individuals (premenopausal 
women) without any sign of metabolic bone diseases. A median of 19.75 wt % 
Ca for CaTURN was found for the adult controls, which was equal to that of the 
young controls. The CaTURN value and the corresponding BMDD parameters are 
listed in Table 1. Estimate of time point when CaTURN is reached (TTURN) is 25 
days based on an average MAR of adults (0.6!m/day). 
 
 
Patients with Osteoporosis (treated with Ca and Vit D): Postmenopausal 
osteoporotic women treated with Ca and Vit-D exhibited a CaTURN of 18.40 wt% 
Ca, which was numerically lower than that of the controls, but this difference did 
not reach level of significance. The only significant difference with respect to 
controls was CaWIDTH (+18%, p=0.008) (Table 1). 
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Figure 34: Comparison of median CaTURN values of healthy adult controls and disease 
cases: PMOP = postmenopausal osteoporosis (calcium & VitD treated) (n=9), UCD = 
not clarified bone disease (n=10); PTH = PTH treatment of OP (n=1); hypoPTsur = 
hypoparathyroidism after surgery (n=1); hypoPTDiG = hypoparathyroidism due to 
developmental disoder -  DiGeorge syndrom (n=1); Osteopetrosis (n=1); Osteonecrosis 
of femoral head (n=4). 
 
 
Patients with Unclear Differential Diagnosis: This patient group presented a 
CaTURN of 17.90 weight % Ca, which was significant lower (-9.4%, p=0.021) 
compared to control. Additionally, CaWidth (+12.7, p=0.043) was increased 
 
Two Patients with HypoPT (Surgery and Di George): The hypoPT patient 
who had a surgical remove of the PT gland exhibited no statistical differences 
compared to adult control, while the hypoPT patient with DiGeorge showed a 
significant lower CaTURN (-24%, p=0.008), when analysed by Wilcoxon signed-
rank test. 
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Patient with PTH treatment: CaTURN of this osteoporotic patient treated for 18 
months with intermittent PTH was found to be lower (-14.4%, p=0.008) 
compared to controls. 
 
Patient with Osteopetrosis: The CaTURN (+4.8%, ns) was numerically higher 
than that of controls but the difference did not reach level of significance. 
 
Patients with Osteonecrosis: The group of patients (n=4) with osteonecrosis 
in the femoral head displayed a slightly lower CaTURN (-13.7%, p=0.048) as 
controls at this skeletal site. 
 
Correlation CaTURN vs BMDD Parameters for all Adult Individuals: 
Correlation analysis between CaTURN and corresponding BMDD parameters of 
all adult individuals did not reveal any correlations (Table 2). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35: Correlation analysis between CaTURN and CaMEAN of adult individuals (healthy  
and diseased) revealed no dependency on CaTURN. 
.
 
diseases/ 
controls 
n age 
range 
CaTURN 
[Ca wt%] 
CaMEAN 
[Ca wt%] 
CaPEAK 
[Ca wt%] 
CaWIDTH 
[DCa wt%] 
CaLOW 
[% B.Ar] 
CaHIGH 
[% B.Ar] 
Control 
 young 
13 2-20 19.75 
[19.50;20.00] 
21.26 
[20.80;21.58] 
21.84 
[21.84;22.36] 
3.47 
[3.29;3.64] 
6.06 
[4.84;6.62] 
1.53 
[1.10;1.86] 
OI type I 
 
5 3-14 21.40** 
[21.40;22.00] 
22.13 
[22.08;22.37] 
22.88 
[22.88;23.22] 
2.95 
[2.77;3.29] 
5.47 
[4.86;6.08] 
3.62 
[2.78;7.72]  
OI type VII 
 
4 2-12 20.75** 
[20.70;20.85] 
21.65 
[21.54;21.73] 
22.43 
[22.36;22.46] 
3.21 
[3.08;3.29] 
6.04 
[5.87;6.26] 
2.52 
[1.97;3.12] 
CaSR 
 
3 13-22 16.35* 
[16.15;16.88] 
18.36 
[18.32;19.05] 
19.06 
[18.89;19.76] 
4.68 
[4.51;1.77] 
31.66 
[22.09;32.75] 
0.17 
[0.15;0.82] 
hypoPT 
DiGorge 
2 14 16.45* 
[16.08;16.83] 
19.35 
[18.87;19.84] 
19.93 
[19.32;20.54] 
5.03 
[4.68;5.37] 
24.30 
[18.18;30.42] 
2.99 
[2.55;3.43] 
HypoPT 
idiopathic 
1 22 15.9* 
[15.45;16.3] 
22.49 23.22 3.12 4.49 7.52 
Control 
adult 
8 pre-
meno-
pausal 
19.75 
[18.43;20.73] 
21.83 
[21.68;22.00] 
22.53 
[22.49;22.57] 
3.38 
[3.12;3.47] 
5.54 
[3.93;6.50] 
3.18 
[2.64;5.56] 
Osteoporosis 
 
9 post-
meno-
pausal 
18.40 
[17.85;18.70] 
22.08 
[21.23;22.21] 
22.88 
[22.01;22.88] 
3.99 
[3.64;4.16] 
5.17 
[4.96;6.33] 
 
Unclear 
diseases  
10 21-58 17.90* 
[17.65;18.10] 
21.81 
[21.68;21.87] 
22.53 
[22.40;22.66] 
3.81 
[3.64;3.94] 
5.29 
[4.51;6.00] 
5.36 
[3.31;7.18] 
PTH-treament  
 
1 49 16.9** 
[16.4;17.5] 
20.79 21.66 4.33   
Osteo- 
petrosis 
1 24 20.7 
[20.6;21.0] 
22.40 23.33 4.33 5.77  
HypoPT 
surgery 
1 49 18.25 
[17.8;18.85] 
22.71 23.40 3.64 3.86 10.40 
HypoPT 
DiGeorge 
1 40 15.0** 
[14.7;15.9] 
22.51 23.05 3.12 3.88 6.49 
Osteo- 
nekrosis 
4 Joche
n? 
17.05* 
[16.28;18.20] 
21.97 
[21.21;22.40] 
23.22 
[22.83;23.57] 
3.21 
[3.12;4.03] 
7.17 
[3.10;14.67] 
5.14 
[1.89;8.52] 
Table 1: Medians of CaTURN and corresponding BMDD-parameters obtained from the group of patients and/or single patients;  
*p<0.05, **p<0.01 indicates significantly difference to corresponding controls.
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 Young Adult 
CaMean r=0.7395 p<0.0001 ns 
CaPeak r=0.7945 p<0.0001 ns 
CaWidth r=-0.7276 p<0.0001 ns 
CaLow r=-0.3636 p=0.0740 ns 
 
Table 2: correlation analysis (nonparametric, after Spearman) between CaTURN and the 
BMDD-parameters. 
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5. DISCUSSION 
 
In the present work bone mineralization density profiles (BM-profiles) were 
measured in sites of forming bone mirroring the time course of matrix 
mineralization starting from level zero (osteoid). This information together with 
the bone turnover is of important clinical interest, because CaTURN and bone 
turnover determine the mineralization status (BMDD) of the bone material of the 
patient. It is a crucial factor of bone strength and thus an important determinant 
of fracture risk.  
 
Biphasic mineralization law 
Since the micrographic imaging of osteonal or trabecular bone by (Jowsey 
1964) it is evident that the bone matrix mineralizes with a special time course, 
so that the young bone osteons or bone packets have lower mineral content 
then the older ones. This was confirmed by the method of fluorescence labeling 
by which the mineralizing front at a bone forming site is marked at two different 
time points usually about 12 days apart. By this method the labeled tissue age 
as well the dynamic parameters of bone formation like mineral apposition rate 
and mineralizing surface can be histological determined. First the combination 
of the fluoresence labeling with the qBEI method allowed to allocate the local 
Ca-content with the duration of mineralization. The results showed that there 
must be a fast initial mineralization process in which already 70 % of final 
mineralization density is performed followed by a slower process (Misof et al. 
2003). Interestingly, as the generation of BMDDs was simulated by 
mathematical computing model, the out come was that a peak shaped BMDD 
can only be produced by an underlying mineralization process, which is 
biphasic, an initial fast and followed by a slow phase (Ruffoni et al. 2007; 
Ruffoni et al. 2008). The presented experimental results based on the analysis 
of bone mineralization density profiles across the mineralization front is 
completely in agreement with this theoretical approach. 
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Mineralization law of children 
Healthy growing children have an 2.5 fold increased bone turnover compared to 
that of adults (Glorieux et al. 2000; Rauch and Glorieux 2004). The bone 
(re)modeling balance is also positive and the bone mass is rapidly increasing by 
this way. Further, the BMDD of children showed a shift towards lower 
mineralization (CaMEAN -5%) compared to adults (Fratzl-Zelman et al. 2009). 
This would be consistent with the increased bone turnover situation in children. 
Indeed, the BM-profile measurements revealed no significant differences 
between children and adults confirming that these differences in BMDD is rather 
not due to changes in the mineralization law than rather due to the increased 
bone turnover. Surprisingly, the BMDD of the young individuals was found to be 
independent of age in the range from 2 to 20 years. This can be understood by 
the fact that in a growing bone the average tissue age remain at a similar low 
level due to the high bone turnover situation. In contrast the BMDD of adults 
was also constant at a higher level in the age range from 25 to 90 yrs, because 
of rather constant lower level of bone turnover (Roschger et al. 2003). 
  
A further interesting novel outcome was, that the investigated children with 
genetic disorder presenting an atypic bone phenotype with characteristic 
changes in the BMDD, which were clearly the results of changes in the 
mineralization law. In the cases of Osteogenesis imperfecta it was a shift 
towards higher mineralization density resulting into a more brittle bone, while in 
the cases with CaSR the shift was towards lower mineralization density, which 
leads to a less stiff bone material.  
 
Osteogenesis Imperfecta: Until now it was well known that the OI generates 
bone with increased mineral content, but the underlying mechanism was still not 
elucidated (Roschger et al. 2008a). It was common sense that the increased 
mineralization density is due to the altered collagen structure as the 
consequence of gene mutation in the collagen gene. However, recent qBEI 
measurements could prove that the different OI types show about the same 
increase in mineralization independent of severity of OI and type of collagen 
mutation or modification. Thus, for example there were no differences in degree 
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of matrix mineralization in OI type I with quantitative (intact collagen but half 
amount) and qualitative mutation (altered collagen structure) (Roschger et al. 
2008a). Further it was found that the bone turnover rate in these children are 
increased compared to healthy control children, which would expect rather a 
shift of the BMDD towards lower mineralization density than to higher 
mineralization (Ruffoni et al. 2007). All together, this leads to the hypothesis, 
that the mineralization process is somehow accelerated most probably due to 
altered osteoblast function. The accelerated mineralization would result then to 
higher mineral contents in all the bone packets formed compared to that of 
controls. Indeed, our finding strongly confirms this hypothesis. In the OI cases  
the CaTURN value, which describes the mineral level where the mineralization 
changes from the rapid primary to the slow secondary mineralization, is 
remarkably increased. This would explain, that, though in OI the bone turnover 
is higher, the BMDD is not shifted towards lower mineralization, because 
already the very new bone packets have increased mineral content. Further, it 
seems that initial lead in mineralization density with respect to controls remain 
during the secondary mineralization phase when the bone packets became 
older.  
 
CaSR patients: This etiology of hypoparathryoidism is associated with an 
activating mutation of the calcium sensing recpector at the parathyroid gland. 
The genetic mutation mimics high calcium levels in the serum, though the level 
is low. In consequence the PTH level is also reduced, because there is no need 
to provide more calcium through activity of osteoclasts. In consequence also 
the bone turnover is markedly suppressed. This scenario would expect, that the 
BMDD is shifted towards higher mineralization and the distribution became 
more narrow, however, the reverse is the case. The BMDD of these patient are 
shifted towards lower mineralization and the BMDD peak was wider. 
Considering the CaTURN of these patients, one can see that this value is 
markedly decreased compared to control children indicating a change in the 
mineralization law towards lower level of primary mineralization, which does not 
seem to be compensated later in the phase of secondary mineralization. Thus, 
the BMDD of CaSR patient decribes a low mineralization status, though the 
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bone turnover is suppressed. About the mechanism of this change in 
mineralization kinetics can only be speculated. Maybe the osteoblast has also a 
CaSR receptor, which is somehow involved in the control of the mineralization 
process. 
 
Mineralization law of adults 
Adults have a lower bone turnover rate compared to children, but a CaTURN in 
the Ca-concentration range as in children was found. Consistently, the BMDD 
was shifted towards higher mineralization density compared to children. 
 
Postmenaupausal osteoporosis: In general these patients have a somewhat 
increased bone turnover acompanied mostly with deficient Calcium and Vit D. 
This lead to a BMDD shifted towards lower mineralization negatively influencing 
the bone strength. Further the remodeling balance between bone formation and 
resorption is negative in this age, that leads to loss of bone mass and structural 
quality. Again this contributes to a reduction of the mechanical competence of 
bone. All together it results in an increase of the fracture incidence in these 
patients. Cacium and Vit D supplementation was found to have a beneficial 
effect on the BMDD (shifts back to normal). Considering the CaTURN in such 
treated patient we could not found differences compared to adult controls. It can 
be concluded therefore that this type of bone fracture disease is rather a 
problem of controlling remodeling activity, while the mineralization process 
seems to be not affected.  
 
Idiopathic Osteoporosis: Most of the investigated biopsies from patients with 
unclear differential diagnosis exhibited a BMDD shifted towards lower 
mineralization, which was not necessarily coupled to an increased bone 
turnover. Interestingly, the CaTURN values of all these patients were decreased 
compared to controls. Hence in this disease it is likely that the mineralization 
process is affected. This novel outcome is of important clinical interest, because 
new therapeutic strategies different from osteoporosis (remodeling disease) 
have to be applied or developed for such patients.  
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Conclusion 
 
In conclusion the measurements of bone mineralization density profiles in bone 
biopsies allows to distinguish between changes of the bone mineralization 
density distribution due to bone turnover and due to disturbances in the 
mineralization process. This differential analysis of the bone matrix 
mineralization status provides a new clinical tool for better diagnosis, and 
treatment decisions in bone diseases. Further it will help to develop new 
therapeutic strategies targeting more accurately the underlying mechanism of 
the disease. 
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Bone mineralization density distribution (BMDD) as assessed by quantitative backscattered electron imaging
(qBEI) in iliac crest bone biopsies has become in the last years a powerful diagnostic tool to evaluate the
effect of metabolic bone diseases and/or therapeutic interventions on the mineralization status of the bone
material. However until now, normative reference data are only available for adults. The aim of the present
study is to close this gap and establish normative data from children and compare them with reference
BMDD data of adults.
qBEI analyses were performed on bone samples from 54 individuals between 1.5 and 23 years without
metabolic bone diseases, which were previously used as study population to establish normative
histomorphometric standards.
In the trabecular compartment, none of the BMDD parameters showed a signiﬁcant correlation with age. The
BMDD was shifted towards lower mineralization density (CaMean −5.6%, pb0.0001; CaPeak −5.6%,
pb0.0001; CaLow +39.0% pb0.001; CaHigh−80.7%, pb0.001) and the inter-individual variation was higher
compared to the adult population.
The cortices appeared to be markedly less mineralized (CaMean−3.1%, pb0.0001) than cancellous bone due
to higher amounts of low mineralized secondary bone. However, the cortical BMDD parameters showed a
strong correlation (r=0.38 to 0.85, with pb0.001 tob0.0001) with cancellous BMDD parameters.
In conclusion, this study provides evidence that BMDD parameters in growing healthy subjects are rela-
tively constant and that these data can be used as normative references in pediatrics osteology. The larger
inter-individual variability compared to adults is most likely related to alterations of the bone turnover rate
during growth.
© 2009 Elsevier Inc. All rights reserved.
Introduction
There is rising interest to include aspects of bone material quality
[1–4] into the diagnosis of bone diseases, the estimation of fracture
risk and treatment decisions. At present, assessment of bone material
quality requires the examination of bone biopsy samples. One of the
key parameters of material quality is mineral density content of the
bone matrix, which determines the stiffness and toughness of bone
material [3]. The local mineralization density of bone tissue can be
measured by various techniques, such as microradiography [5,6],
synchrotron radiation microcomputed tomography [7,8] and quanti-
tative backscattered electron imaging (qBEI) [9].
The bone mineralization density distribution (BMDD) provides
important information about the effect of metabolic bone diseases and
therapeutic interventions on the mineralization of the bone material
[9–12]. Reference data for trabecular BMDD in adults are available for
the age range from 25 to 90 years [13]. These show a remarkably small
inter-individual variation (coefﬁcient of variation of less than 1.7%) in
BMDD, suggesting that even small deviations have biological
relevance. Indeed, low matrix mineralization was found in osteo-
porosis [14,15] and mild primary hyperparathyroidism [16] while a
shift towards higher mineralization was found in osteogenesis
imperfecta [17,18].
At present, the use of BMDD in pediatric populations is hampered
by the lack of reference data for the age range below 25 years. In
previous studies we therefore compared BMDD values of children and
adolescents either with adults [19] or with individually age-matched
controls [9,18,20]. However, comparison with adult data is certainly
not ideal, as preliminary data suggest that trabecular bone matrix
is less mineralized in children than in adults [7,21]. Comparison
with age-matched controls is cumbersome and requires access to
the raw data of control subjects. Establishing pediatric reference
data for BMDD is therefore important for assessing pediatric bone
diseases by qBEI and would also yield new insights into normal bone
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development. We therefore performed qBEI analyses of complete
transiliac bone biopsy specimen from children, adolescents and young
adults without metabolic bone diseases.
Materials and methods
Subjects
The study population comprised 54 Caucasian subjects aged from
1.5 to 23 years (32 female, 22 male). Bone biopsies were performed
during surgery for various orthopedic conditions, such as lower limb
deformities, scoliosis, clubfeet and other problems that require
corrective surgery (exostoses, cubitus valgus and equinovarus of the
foot). All subjects were ambulatory, had normal renal function as
assessed by measurement of serum creatinine and had no evidence of
anymetabolic bone disease. Nonewas immobilized prior to surgery or
received medications known to affect bone metabolism. This cohort is
part of a larger population that has been presented before to establish
reference data for histomorphometric parameters in cancellous and
cortical bone [22–24].
Quantitative backscattered electron imaging (qBEI)
Quantitative backscattered electron imaging was employed to
visualize and quantify the local mineralization density in transiliac
bone biopsy samples. The physical principle of the technique is based
on a quantiﬁcation of the intensity of electrons backscattered from the
surface of a sectioned bone area. The obtained signal is proportional to
the weight fraction of calcium (Ca wt.%) present locally in the
embedded bone tissue. Full details of the technique have been
described elsewhere [10,13]. Blocks containing polymethylmethacry-
late-embedded undecalciﬁed iliac bone samples were prepared for
Fig. 1. Backscattered electron images and corresponding BMDD of a transiliac bone biopsy of a 12-year-old study participant. Overview of the entire biopsy sample showing the
asymmetric aspect of the two cortices: (A) The external cortex (Ex.Ct) is characterized by periosteal primary bone and endocortical cancellation while the internal cortex (In.Ct) is
characterized by periosteal eroded surfaces and endocortical encroaching of trabecular features. (B) Detail of external cortex. (C) Detail of cancellous bone. (D) Detail of internal
cortex. (E) BMDD curves corresponding to the Ex.Ct and internal In.Ct as well as cancellous bone (Cn). (F) Calcium content proﬁle through the external cortex from the periosteal to
the endocortical surface as indicated by the white line. Arrows indicate the region of primary periosteal bone.
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qBEI by grinding and polishing in order to obtain plane and parallel
surfaces. The sample surface was then carbon coated. Quantitative BEI
was performed in a digital scanning electron microscope (DSM 962,
Zeiss, Oberkochen, Germany) equipped with a four-quadrant semi-
conductor backscattered electron detector. The microscope was
operated at 20 keV electron energy and a probe current of 110 pA.
A series of backscattered electron images using a pixel resolution
of 2 μm (as shown in Figs.1B to D) were performed covering the entire
biopsy area including both cortices and the cancellous bone
compartment. Mineralized bone tissue were segmented from soft
tissue including osteoid and marrow space ﬁlled with embedding
medium by grey level thresh holding [10,11]. Cancellous bone was
separated from the cortical bone as indicated by the dashed line in
Fig. 1A. Thereby the line was following the bone tissue where the
compact bone character is changing into a cancellous one (subjec-
tively). In the age range of 1.5 to 14 years morphological features as
visualized by qBEI allowed us to assign the two cortices to external
(Ex.Ct) and to internal (In.Ct) cortices (see Fig. 1) [24]. However, for
ages above 14 years the above mentioned morphological features
disappeared and hampered the discrimination between external and
internal cortices. Hence, for the entire age range 1.5 to 23 years only
one set of the BMDD data for cortical bone, the average of the two
cortices was determined.
From the grey level images obtained by the area scans, grey level
frequency histograms were derived and converted by calibration [10]
to BMDD. BMDD curves indicate the frequency of pixels corresponding
to speciﬁc calcium contents occurring throughout the sample area.
BMDD curves were evaluated separately for the trabecular compart-
ment and the two cortical compartments (Fig. 1 E).
For statistical analysis, ﬁve parameters characterizing the BMDD
curve were determined, as described in detail elsewhere [9,13] (see
Fig. 2):
• CaMean, the weighted mean calcium concentration of the bone
area obtained by the integrated area under the BMDD curve;
• CaPeak, the peak position of the histogram, which indicates the
most frequently occurring calcium concentration (calcium value
with the highest number of pixels) in the bone area;
• CaWidth, the full width at half maximum of the distribution,
describing the variation in mineralization density;
• CaLow, the percentage of bone area that is mineralized below the
5th percentile of the reference BMDD of normal adults [13], that is
below 17.68 wt.% calcium. This parameter corresponds to the
amount of bone area undergoing primary mineralization.
• CaHigh, the percentage of bone area that is mineralized above the
95th percentile of the reference BMDD of normal adults that is
above 25.30 wt.% calcium. This parameter corresponds to the
amount of bone having achieved plateau level of normal miner-
alization and includes also the contribution of highly mineralized
cement lines [9].
Statistical analyses
Statistical analysis was performed using SigmaStat for Windows
Version 2.03 (SPSS Inc.). The relationship between BMDD parameters
and age was tested by Spearman rank order correlation tests.
Comparisons of BMDD parameters between the present study group
and those of an adult reference population were done by t-test or
nonparametric by Mann–Whitney test when appropriate. Differences
of BMDD parameters between spongiosa, and cortical bone were
tested by Friedman repeated measures ANOVA on ranks followed by
Tukey pairwise comparison. Not normally distributed data are given
by median and interquartile range in Table 1. Correlations between
results in trabecular and cortical bone were calculated by Pearson or
Spearman correlation coefﬁcients when appropriate (Table 2).
Results
Trabecular bone
In trabecular bone, none of the BMDD parameters varied
signiﬁcantly with age (Fig. 3A). Statistical t-test between the male
and female group did not reveal differences in BMDD parameters
either. The corresponding p-values ranged from 0.31 to 0.95.
Consequently, a single reference BMDD of trabecular bone could be
constructed for the entire age range from 1.5 to 23 years (Fig. 3B).
Table 1 presents these results in numerical format.
Compared to the adult reference population [13], the present study
population had lower average mineralization density, as expressed by
5.6% lower results for CaMean and CaPeak (Table 1, Fig. 3B).
Correspondingly, samples from the younger population contained
39% more areas with low mineralization, and 81% less areas with fully
mineralized bone (pb0.001 in both cases; Table 1). The average
intraindividual heterogeneity of mineralization (i.e., CaWidth) was
not signiﬁcantly different between groups (p=0.52). However, the
Fig. 2. The BMDD curve of normal human adult trabecular bone. All BMDD parameters
used in this article (CaMean, CaPeak, CaWidth, CaLow, CaHigh) are indicated in this
curve. Note that CaLow and CaHigh are deﬁned in relation to this reference BMDD of
adults [9].
Table 1
Cancellous BMDD parameters in the present study population compared to reference
data for cancellous BMDD in adults [13] and to cortical BMDD parameters of the present
study population.
Adults Present study population
Cancellous bone
(n=52)
Cancellous bone
(n=54)
Cortex
(n=53)
CaMean [wt.% Ca] 22.20 (0.45) 20.95a (0.57) 20.31b (0.93)
CaPeak [wt.% Ca] 22.94 (0.39) 21.66a (0.52) 21.14b [20.62; 21.75]
CaWidth [Δwt.% Ca] 3.29 [3.12; 3.47] 3.47 [3.12; 3.64] 3.81b [3.38; 4.38]
CaLow [%] 4.52 [3.87; 5.79] 6.14a [4.90; 7.99] 9.06b [6.22; 15.00]
CaHigh [%] 4.62 [3.52; 6.48] 0.89a [0.43; 1.47] 0.46b1 [0.28; 1.22]
Data shown are mean (SD) or median [25%; 75%].
a signiﬁcant difference (pb0.0001) in cancellous bone results between adults and the
present study population.
b, b1 signiﬁcant difference (pb0.0001, pb0.01) to cancellous bone result in the
present study population.
Table 2
Correlations of cortical with cancellous BMDD parameters of the present study
population.
Cortical vs. cancellous bone
CaMean r=0.85, pb0.0001
CaPeak r=0.83, pb0.0001
CaWidth r=0.38, pb0.01
CaLow r=0.75, pb0.0001
CaHigh r=0.72, pb0.0001
Data shown are the correlation coefﬁcient r and the corresponding p-value.
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interindividual variability of mineralization density was slightly
higher in the present study population than in adults. E.g., the
interindividual coefﬁcient of variation in CaPeak was 1.7% in the adult
group and 2.4% in our present cohort (Table 1).
Cortical bone
BMDD parameters of cortical bone (mean of both cortices) were
signiﬁcantly correlated to those of trabecular bone (Table 2). Never-
theless, the mineralization density of cortical bone was markedly
lower and more heterogeneous than that of trabecular bone (Table 1,
Fig. 1). This was explained by the observation that cortical bone
contained more areas undergoing primary mineralization and fewer
areas of fully mineralized bone (Fig. 1, Table 1).
Though in the age range 1.5 to 14 years the two cortices, the
external and internal cortices, exhibited an asymmetric aspect, the
mineralization density (CaMean −0.98%) was only slightly lower for
internal compared to external cortex (data not shown). In the external
cortex, bone tissue close to the periosteal surface was more highly
mineralized than bone adjacent to the endocortical surface (Figs. 1B
and F). The internal cortex contained remnants of highly mineralized
trabeculae. The areas between these trabecular remnants were ‘ﬁlled’
with large amounts of newly formed and lower mineralized bone
(Fig. 1D). The periosteal surface of the internal cortex often presented
an eroded aspect (Fig. 1D).
Discussion
The main ﬁndings of this study are that BMDD parameters of iliac
trabecular bone are constant from 1.5 to 23 years of age and that
matrix mineralization density is lower in cortical than in trabecular
bone. In addition there was a strong correlation of the BDDD
parameters between cortical and trabecular bone. These observations
need to be interpreted in light of the mineralization process and of
normal iliac bone development.
The lack of age dependency of BMDD parameters in these biopsies
during growth of individuals, which is consistent with a previous
study [17], is somewhat surprising and requires closer analysis: First,
in children and adolescents, the site of biopsy is located at
approximately 1 cm below the apophyseal iliac growth plate. During
human skeletal development, this growth plate is one of the last to
fuse [25]. It can therefore be assumed that in most of our study
participants this growth plate was active when the biopsy was
performed. This means that even though our study population varied
widely in chronological age, the age of the bone tissue at the site of
biopsy was presumably similar between study participants. Second, it
Fig. 3. Relationship of BMDD parameters with age. (A) The dotted lines indicate the linear ﬁts. However none of the parameters showed a signiﬁcant correlation with age. (B)
Reference BMDD curve for trabecular bone for the age range from 1.5 to 23 years. The grey band indicates the 95% conﬁdence interval (C.I.) for the individual histogram values. For
comparison the reference BMDD curve of adults (25 to 90 years of age) is shown too.
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has been shown that trabecular bone in the growing skeleton is
subjected to a high rate of bone turnover with a small positive balance
towards new bone acquisition [26]. Hence, in a situation of high bone
turnover – and independently of age – the BMDD is shifted towards
lower mineralization [9,12,14,16,27]. This is due to the fact that newly
formed bone matrix is rapidly mineralized (within a few days) up to
only 70% (primary mineralization) of fully mineralized bone matrix
and the full mineralization lasts years (secondary mineralization).
Consistently, a recent mathematical model showed that the most
frequently occurring calcium concentration (CaPeak) decreases in
situations of high bone turnover [28]. Therefore, the average degree of
mineralization depends on the age of the bone tissue. High bone
turnover decreases the average age of bone tissue and therefore is
associated with increased CaLow and decreased CaPeak and CaMean
[28,29]. Presumably, the continuing endochondral bone formation
process and the subsequent high remodeling activity thus contribute
to maintain bone tissue age fairly constant, which explains why the
mineralization density of the bone matrix did not change with the
chronological age of study participants. Once the growth process is
completed, the bone tissue ‘ages’ rapidly. This means that mineraliza-
tion density increases rapidly until a new steady state is achieved, the
level of which depends on the prevailing remodeling rate [28].
Therefore, the mineralization density of iliac trabecular bone is higher
in adults than during development.
Further, the BMDD data reﬂected the distinctive development of
the cortices. According to previous studies, the developing ilium
increases in width due to a lateral modeling drift of both cortices
[23,26]. The outer cortex is expanding through periosteal bone
apposition and is partially resorbed and transformed into trabecular
bone on the endocortical side. In contrast, the inner cortex expands by
endocortical apposition, and thus encroaches on the trabecular
compartment. During this process, trabeculae are incorporated into
the inner cortex and the space between trabeculae is ﬁlled up with
new bone tissue.
The qBEI method shows that the primary bone produced by the
periosteal osteoblasts of the external cortex is more highly miner-
alized than the adjacent bone tissue that has undergone intracortical
remodeling and thus constitutes secondary bone. As the amount of
this high-density primary bone is generally much less than that of
the low-density secondary bone, the overall mineralization density
of the external cortex is lower and more heterogeneous than that of
the cancellous bone. Interestingly, this primary periosteal bone
matrix with increased mineralization density, which has already
described using microradiography [30], is known to have a different
lamellar structure than secondary bone [23]. It seems that the mine-
ralization process of this bone matrix is accelerated. Otherwise, the
mineralization density would be distinctly lower, because of its
relatively young age in this cortical bone region. Such rapid
formation of highly mineralized periosteal bone tissue in the
developing skeleton might represent an efﬁcient mechanism to
establish rapidly some mechanical competence by forming ﬁrst a
rigid scaffold, which is remodeled and optimized later on. This
strategy seems to be analogous to the formation of highly
mineralized callus tissue in fracture healing [31,32].
In contrast, the internal cortex of the ilium does not contain
primary bone in growing individuals, as the formation drift occurs on
the endocortical surface [23,26]. Consequently, the internal cortex is
composed of a mixture between relatively old and highly mineralized
trabecular remnants and new bone matrix with low mineralization.
The average mineralization density therefore is below that of
trabecular bone. Thus, consistent with previous observations that
were made with a different experimental approach, the average
mineralization density during development is lower in cortical than in
trabecular bone [17]. As discussed, this is presumably the result of
modeling drifts. When the modeling drifts come to a halt at the end of
bone development, the mineralization density of cortical bone should
increase. In adults, CaPeak of cortical bone is indeed similar or higher
than that of trabecular bone [33].
Moreover, it is remarkable, that the cortical BMDD parameters
were strongly correlated to those of trabecular bone. This suggests a
certain “coupling” of bone turnover rate between cortical and
trabecular bone compartments in these young individuals.
In conclusion, the present study shows that trabecular BMDD of
transiliac biopsy samples remains constant from 1.5 to 23 years of
age and that the cortical BMDD is different, but strongly correlated to
the trabecular BMDD in each individual. Therefore, the reference
values for trabecular and cortical bone as well its correlation to each
other derived in this study can be used for the entire age range. It
should be emphasized, that due to the higher variability in BMDD,
the usage of the normative data deduced from 54 individuals might
be more reliable than the usage of age-matched controls. These data
should increase the use of qBEI in the assessment of pediatric bone
biopsy samples.
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